Introduction {#s1}
============

Multipotent intestinal stem cells (ISCs) are responsible for tissue homeostasis in the adult *Drosophila* midgut ([@bib30]; [@bib46]; [@bib48]). Similar to the mammalian digestive epithelium, the activity of ISC proliferation and differentiation increases upon tissue damage ([@bib2]). Although signaling pathways controlling ISC activity, such as Ras/MAPK ([@bib32]), Hippo/Yki ([@bib36]; [@bib62]), and JAK/Stat ([@bib33]), play critical roles in gut homeostasis, the mechanisms modulating these pathways under different physiological and pathological conditions are not well understood. In particular, it is unclear how ISCs sense microenvironment signals under tissue damage conditions to upregulate the activity of mitogenic pathways such as Ras/MAPK. The simplicity of the *Drosophila* midgut and the ease of performing genetic screens provide a powerful system to study how stem cells sense microenvironment cues and adjust their activities accordingly.

The concentration of reactive oxygen species (ROS) is emerging as a critical microenvironment signal that regulates stem cell activity in neuronal and glial progenitors ([@bib43]; [@bib64]; [@bib72]), as well as in mammalian hematopoietic stem cells (HSCs) ([@bib71]) and *Drosophila* hematopoietic progenitors ([@bib50]). In most cases, high ROS concentration stimulates, at least in the short term, the activity of stem cells by driving them out of an otherwise quiescent status. In mammals, oxidative stress is associated with intestine damage and inflammatory bowel disease ([@bib59]). In the *Drosophila* midgut, high ROS levels are produced in response to different types of tissue damage ([@bib23]; [@bib27]; [@bib40]). Moreover, oxidants such as paraquat and hydrogen peroxide are commonly used to induce tissue damage ([@bib8]). Although high ROS levels in ISCs are sufficient to trigger ISC proliferation ([@bib27]), the connection between oxidative stress and mitogenic signals in ISCs remains obscure.

We performed an in vivo RNAi screen to identify novel components required for ISC proliferation in response to tissue damage. In the screen, we identified two cation channels, transient receptor potential A1 (TRPA1) and ryanodine receptor (RyR), which are required for ISC self-renewal and damage-induced proliferation. We show that these channels are required for Ca^2+^ homeostasis in ISCs and mediate increases in cytosolic Ca^2+^ in response to oxidative stress and ISC proliferation. Our results are consistent with a recent study ([@bib13]) showing that high cytosolic Ca^2+^ in ISCs can stimulate proliferation. Finally, we characterize the signaling events downstream of cytosolic Ca^2+^ increase and demonstrate that Ras/MAPK mediates the effects of Ca^2+^ on ISC proliferation.

Results {#s2}
=======

TRPA1 and RyR are required for stem cell damage response and self-renewal {#s2-1}
-------------------------------------------------------------------------

From an RNAi screen for new transmembrane proteins required for ISCs proliferation, we identified TRPA1 and RyR as candidate hits required for ISC pool size maintenance and damage-induced ISCs proliferation (see Materials and methods). We confirmed that the lines producing a consistent phenotype (v37249, BL31504 for TRPA1; BL29445 for RyR) effectively knockdown the corresponding transcripts, while the lines that did not score as hits from our screen (BL31384, BL36780 for TRPA1; BL31540, BL31695 for RyR) cannot achieve efficient knockdown ([Figure 1---figure supplement 1C--D](#fig1s1){ref-type="fig"}).

TRPA1 is a Ca^2+^-permeable cation influx channel ([@bib74]). RyR is an endoplasmic reticulum (ER) cation channel that releases ER Ca^2+^ into the cytosol ([@bib61]). RNAi-mediated knockdown of either *trpA1* or *RyR* in adult ISCs completely blocked proliferation induced by the tissue-damaging agent paraquat or bleomycin ([Figure 1A--C and A'-C', G](#fig1){ref-type="fig"}). Depletion of *trpA1* or *RyR* causes a gradual loss of the stem cell population, with a significant decrease in esg+ cell density undetectable until 7 days of RNAi expression ([Figure 1---figure supplement 1E](#fig1s1){ref-type="fig"}). The RNAi lines do not cause stem cell apoptosis, because cell death cannot be detected with anti-cleaved-caspase 3 staining in the midgut ([Figure 1---figure supplement 2A--C](#fig1s2){ref-type="fig"}), and the anti-apoptotic gene *p35* ([@bib25]) cannot rescue the mitosis defect caused by *trpA1* RNAi or *RyR* RNAi ([Figure 1---figure supplement 2D--I,D'--I'](#fig1s2){ref-type="fig"}). In contrast, mitosis activity in stem cells expressing *trpA1* RNAi or *RyR* RNAi can be regained by forced cytosolic calcium influx with RNAi against *SERCA* ([Figure 1D--G](#fig1){ref-type="fig"}), an ER Ca^2+^ ATPase whose inhibition triggers Stim/Orai channel (SOC)-mediated Ca^2+^ entry into the cytosol ([@bib10]). Altogether, these results place cytosolic calcium signaling genetically downstream of TRPA1 and RyR during ISC proliferation. Consistent with the results obtained with RNAi, CRISPR/Cas9-mediated knockout of *trpA1* or *RyR* in adult ISCs suppressed damage-induced proliferation ([Figure 1H](#fig1){ref-type="fig"}). In addition, at the organ level, inhibition of ISC proliferation by *trpA1* RNAi is associated with a shortening in midgut length ([Figure 1I](#fig1){ref-type="fig"}). Further, while wild-type midguts maintain their proper length after feeding paraquat or bleomycin for 2 days, midguts with *trpA1* RNAi expression in the ISCs exhibit accelerated shortening following tissue damage. This damage-induced midgut shortening phenotype is reminiscent to the gut phenotype observed after depletion of the esg+ cell population when the cell death gene *reaper* (*rpr*) is expressed in ISCs for 4 days ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}), suggesting the importance of ISC activity for maintaining tissue size.10.7554/eLife.22441.002Figure 1.The calcium channels TRPA1 and RyR are required for damage-induced ISC proliferation.(**A--C**) Midguts overexpressing *Luc* RNAi, *trpA1* RNAi or *RyR* RNAi in ISCs using EGT (esgGal4 UAS-GFP tubGal80^ts^) for 6d, were fed the oxidant agent paraquat for the last 2d (**A'--C'**) or co-expressed with *SERCA* RNAi (**D--F**). Midguts are stained for the mitosis marker phosphohistone H3 (pH3). *Luc* RNAi is used as control. ^ts^ stands for temperature sensitive tubGal80ts that allows for temporal control of genetic manipulation. GFP is used to report the expression pattern of esgGal4. (**G**) Quantification of mitosis (pH3+ cell number) of midguts expressing *Luc* RNAi, *trpA1* RNAi or *RyR* RNAi in ISCs under normal condition, 2 mM paraquat feeding, 25 µg/ml bleomycin feeding, or co-expression with *SERCA* RNAi. N \> 5 midguts are quantified per genotype per treatment. Data are represented as mean ± SEM. Double asterisks indicate a p value of less than 0.01. (**H**) Mitosis quantification of midguts with constitutive expression of sgRNA targeting *trpA1* or *RyR*, and targeted Cas9 expression in ISCs for 7d (bleomycin feeding for the last 2d). Flies with the same genetic background but only empty insertional landing site are used as the control for sgRNA. Data are represented as mean ± SEM. Note that we generally observed that CRISPR/Cas9-mediated knockout in vivo is not working as efficiently as RNAi, probably because not all DNA damages by CRISPR/Cas9 result in frame-shift mutations. N \> 6 midguts are analyzed per genotype. Data are represented as mean ± SEM. (**I**) Length quantification of midguts expressing *Luc* RNAi (control) or *trpA1* RNAi for 7d, with the last 2d feeding on normal food, paraquat, or bleomycin. The average midgut length of control flies feeding on normal food is used for normalization. N \> 5 midguts are analyzed per genotype per treatment. Data are represented as mean ± SEM.**DOI:** [http://dx.doi.org/10.7554/eLife.22441.002](10.7554/eLife.22441.002)10.7554/eLife.22441.003Figure 1---source data 1.Complete results for [Figure 1G--I](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1E](#fig1s1){ref-type="fig"}, [Figure 1---figure supplement 3A--B](#fig1s3){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.22441.003](10.7554/eLife.22441.003)10.7554/eLife.22441.004Figure 1---figure supplement 1.Validation of knockdown efficiency for *trpA1* RNAi and *RyR* RNAi lines.(**A**) Cartoon depicting the four characterized *trpA1* isoforms. The target regions of *trpA1* RNAi lines used in this study are shown in dashed rectangles. The regions amplified with isoform-specific primers are shown in square brackets. (**B**) Primers spanning exons for specific splicing events are used in RT-PCR to distinguish *trpA1* isoform expression in fly midguts and heads. (**C**) RT-qPCR analysis of mRNAs from midguts expressing different lines of *trpA1* RNAi ubiquitously with inducible DaGal4ts for 5d, with primers designed for different types of *trpA1* isoforms. *GAPDH* and *rp49* are reference genes for normalization. To determine RNAi knockdown efficiency, the ratio of normalized *trpA1* expression to corresponding control groups expressing either *Luc* RNAi (for BL lines) or carrying an empty insertional landing site (v60100 for v37249) is calculated. The data are presented as mean ± SEM for three technical replicates. We repeated the experiments (two biological replicates) and observed consistent results. (**D**) RT-qPCR measurement of midguts ubiquitously expressing *Luc* RNAi or *RyR* RNAi for 5d, with two different sets of primers designed for all *RyR* isoforms. *GAPDH* and *rp49* are used for normalization. The data are presented as mean ± SEM for three technical replicates. We repeated the experiments (two biological replicates) and observed consistent results. (**E**) Quantification of relative esg+ cell density in the posterior midgut region. esg+ cell number is divided by the imaged area size for density calculation. N \> 5 midguts per genotype per time point are analyzed. Data are represented as mean ± SEM.**DOI:** [http://dx.doi.org/10.7554/eLife.22441.004](10.7554/eLife.22441.004)10.7554/eLife.22441.005Figure 1---figure supplement 2.*trpA1* RNAi and *RyR* RNAi do not cause ISC apoptosis.(**A--C**) Immunostaining of midguts expressing *Luc* RNAi, *trpA1* RNAi or *RyR* RNAi in ISCs for apoptosis marker cleaved-caspase 3. The channels of cleaved-caspase 3 signal are shown to the right of the merged images. No signal can be detected except some background staining in the trachea and muscle. (**D--F**) Midguts expressing *Luc* RNAi, *trpA1* RNAi or *RyR* RNAi in ISCs with the last 2d feeding 2 mM paraquat (**D'--F'**), are stained for mitosis marker pH3. (**G--I**) Midguts expressing anti-apoptosis protein p35, together with *Luc* RNAi, *trpA1* RNAi or *RyR* RNAi in ISCs with the last 2d feeding 2 mM paraquat (**G'--I'**), are stained for mitosis marker pH3.**DOI:** [http://dx.doi.org/10.7554/eLife.22441.005](10.7554/eLife.22441.005)10.7554/eLife.22441.006Figure 1---figure supplement 3.ISC depletion results in midgut shortening.(**A**) Length quantification of midguts with inducible expression of rpr in ISCs. In the 'rpr off' group, the flies are kept at 18°C to prevent Gal4 activity and rpr expression; in the 'rpr on' group, rpr expression is induced at 29°C for 4d and turned off at 18°C for 3d feeding normal food or bleomycin; in the 'post-rpr' group, after 4d expression of rpr, the flies are placed back at 18°C for specified days before bleomycin treatment. N \> 6 midguts are analyzed per genotype per treatment. Data are represented as mean ± SEM. (**B**) Mitosis quantification of midguts with inducible expression of rpr in ISCs. Mitosis activity in the midgut cannot recover after depletion of the esg+ cell population by 4d rpr expression, N \> 7 midguts are analyzed per genotype per treatment. Data are represented as mean ± SEM.**DOI:** [http://dx.doi.org/10.7554/eLife.22441.006](10.7554/eLife.22441.006)

To determine whether TRPA1 and RyR act in a cell-autonomous manner, we generated GFP+ clones originating from ISCs that are deficient for either *trpA1* or *RyR* using the MARCM method ([@bib76]). MARCM clones generated from ISCs expressing *trpA1* RNAi ([Figure 2A'](#fig2){ref-type="fig"}), or homozygous for the loss-of-function allele *trpA1^1^* ([@bib39]) ([Figure 2B'](#fig2){ref-type="fig"}), or *RyR^k04913^* ([@bib67]) ([Figure 2C'](#fig2){ref-type="fig"}) had a smaller average size compared to wild-type clones 10 days after clonal induction ([Figure 2A--C](#fig2){ref-type="fig"}, *trpA1* RNAi and *RyR^k04913^* clone sizes are quantified in [Figure 2D](#fig2){ref-type="fig"}), suggesting that TRPA1 and RyR are required autonomously for clonal expansion. Although smaller than wild-type clones, MARCM clones expressing *trpA1* RNAi or losing *RyR* can survive and differentiate into Pdm1+ enterocytes (ECs) ([Figure 2---figure supplement 1A--D](#fig2s1){ref-type="fig"}). We also performed lineage tracing with the EGT F/O system ([@bib31]), which relies on induced expression of Flp in the stem cells to excise transcriptional STOP cassettes flanking act::Gal4, and found that stem cells expressing *trpA1* RNAi can still differentiate into mature Pros+ enteroendocrine cells (EEs) or Pdm1+ ECs ([Figure 2---figure supplement 1E--H](#fig2s1){ref-type="fig"}). Furthermore, while Dl+ cells ([Figure 2D--F and L](#fig2){ref-type="fig"}) are dramatically decreased by *trpA1* RNAi or *RyR* RNAi expression for 5 days, there was no significant change in the density of Su(H)Gbe+ or Pros+ cells ([Figure 2G--I and M](#fig2){ref-type="fig"}). The Notch pathway reporter Su(H)GbeGFP is indicative of ISC differentiation activity because Notch signaling is high when ISCs differentiate, especially for the EC lineage ([@bib46]; [@bib49]). Altogether, our data suggest that *trpA1* RNAi or *RyR* RNAi mainly affects ISC self-renewal and proliferation in the adult gut, rather than ISC differentiation or cell death.10.7554/eLife.22441.007Figure 2.TRPA1 and RyR are required for ISC self-renewal but not differentiation.(**A--C, A'--C'**) MARCM clones deficient for TRPA1 or RyR are analyzed along with their corresponding control genotypes (A for A', B for B', C for C') 10d after clone induction. Cell numbers per clone for MARCM clones expressing *trpA1* RNAi, or lacking both wild-type *RyR* alleles, are quantified in (**J**). Randomly picked N = 35 clones from the posterior regions of five guts per genotype are analyzed. Data are represented as mean ± SEM. (**D--F**) ISC marker Dl-lacZ stainings of midguts expressing *Luc* RNAi, *trpA1* RNAi or *RyR* RNAi for 5d in ISCs. The relative Dl+ cell density in the posterior midgut region is quantified in (**K**). Dl+ cell number is divided by the imaged area size for density calculation. N \> 5 midguts per genotype are analyzed. Data are represented as mean ± SEM. (**G--I**) Immunostaining of midguts expressing *Luc* RNAi, *trpA1* RNAi or *RyR* RNAi for 5d in ISCs for Notch activity reporter Su(H)GbeGFP and EE marker Prospero (pros). The relative Su(H)Gbe+ cell density in the posterior midgut region is quantified in (**L**). Su(H)Gbe+ cell number is divided by the imaged area size for density calculation. N \> 4 midguts per genotype are analyzed. Data are represented as mean ± SEM. (**M**) Quantificatioin of EE density in the posterior midgut region for midguts expressing *Luc* RNAi, *trpA1* RNAi or *RyR* RNAi in ISCs for 3d, 5d, and 7d. For each time point, EE density is normalized to the average value of midguts expressing *Luc* RNAi. N \> 4 midguts per genotype are analyzed. Data are represented as mean ± SEM.**DOI:** [http://dx.doi.org/10.7554/eLife.22441.007](10.7554/eLife.22441.007)10.7554/eLife.22441.008Figure 2---source data 1.Complete results for [Figure 2J--M](#fig2){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.22441.008](10.7554/eLife.22441.008)10.7554/eLife.22441.009Figure 2---figure supplement 1.Lineage-tracing experiments provide evidence that TRPA1 or RyR-deficient ISCs can differentiate.(**A--B**) MARCM clones expressing *Luc* RNAi or *trpA1* RNAi for 22d are examined for their survival and stained with anti-Pdm1 antibody to examine EC differentiation. Arrowheads highlight examples of ECs generated from ISCs expressing *Luc* RNAi or *trpA1* RNAi. (**C--D**) MARCM clones that are homozygous RyR mutant are stained with anti-Pdm1 antibody. Arrowheads highlight examples of ECs in the MARCM clones that are Pdm1+. (**E--F**) Immunostaining of midguts expressing *Luc* RNAi or *trpA1* RNAi in the ISC lineage (labeled by GFP) for EE marker, Pros. Arrowheads highlight examples of EEs generated by ISCs during the 6d period of tracing. (**G--H**) Immunostaining of midguts expressing *Luc* RNAi or *trpA1* RNAi in the ISC lineage (labeled by GFP) for EC marker, Pdm1. Arrowheads highlight examples of ECs generated by ISCs during the 6d period of tracing.**DOI:** [http://dx.doi.org/10.7554/eLife.22441.009](10.7554/eLife.22441.009)

TRPA1 and RyR expression in the midgut {#s2-2}
--------------------------------------

The *trpA1* gene is expressed as multiple mRNAs ([Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}), four of which have been characterized previously ([@bib80]). Compared to the TRPA1-A and -B isoforms, expressed in the fly head, TRPA1-C and -D isoforms are expressed in the midgut ([Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}) and have different N-terminal residues that might confer sensitivity to different stimuli. Based on anti-TRPA1 staining, TRPA1 appears to be expressed in stem cells ([Figure 3A--B](#fig3){ref-type="fig"}). Using a Gal4 fused to the C terminal of *trpA1* transcripts via CRISPR/Cas9-mediated knock-in at the endogenous locus ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}), we could also detect *trpA1* expression in stem cells in the anterior region of the posterior midgut ([Figure 3C](#fig3){ref-type="fig"}). Consistently, stem cell depletion reduces *trpA1* total mRNA expression in the midgut by more than 50% ([Figure 3---figure supplement 2A](#fig3s2){ref-type="fig"}). Because the signal-to-noise ratio for anti-TRPA1 staining is low, and *trpA1*Gal4^CP2A^ might not fully recapitulate the endogenous expression pattern, we cannot exclude the possibility that *trpA1* is also expressed in other cell types. In a recent study, for example, TRPA1-C has been identified to regulate defecation of food-borne pathogens in the EEs ([@bib15]). However, TRPA1 is mainly required in ISCs for proliferation, because knockdown of *trpA1* in self-renewing ISCs, rather than in differentiating ISCs (Su(H)Gbe+ cells, also called enteroblasts (EBs)) or visceral muscles, blocks damage-induced proliferation ([Figure 3---figure supplement 2B](#fig3s2){ref-type="fig"}). Further, an additional piece of evidence that TRPA1 protein functions in the stem cells comes from the ex vivo calcium-imaging experiments with GCamP6f reporter, for which the intensity of green fluorescence indicates cytosolic calcium levels ([@bib9]). While the TRPA1 agonist AITC (allyl isothiocyanate ([@bib4]) can induce calcium influx in ISCs carrying a wild-type allele of *trpA1*, such response is abolished in flies losing both alleles of wild-type *trpA1* ([Figure 3E--F](#fig3){ref-type="fig"}).10.7554/eLife.22441.010Figure 3.*trpA1* and *RyR* expression in the midgut.(**A--B**) Anti-TRPA1 immunostaining of midguts expressing *Luc* RNAi or *trpA1* RNAi in ISCs. The channel of anti-TRPA1 signal is shown below the merged image. Note that anti-TRPA1 staining has high background signal. While we could detect TRPA1 expression in the ISCs, we could not exclude the possibility that it is also expressed in other cell types. (**C**) *trpA1*Gal4*^CP2A^*-driven expression of mCherry is co-stained with ISC marker esglacZ. (**D**) *RyR*Gal4*^R14G09^* (enhancer region of RyR locus) driven expression of membrane-localized CAAX-mCherry is co-stained with ISC marker esgGFP. (**E--F**) Imaging midguts missing one or both alleles of wild-type *trpA1* with GCaMP6f expression in ISCs. The same guts are imaged again after exposure to 0.015% AITC in the imaging buffer for 5 min (**E'--F'**). The images are acquired on a Keyence microscope.**DOI:** [http://dx.doi.org/10.7554/eLife.22441.010](10.7554/eLife.22441.010)10.7554/eLife.22441.011Figure 3---source data 1.Complete results for [Figure 3---figure supplement 2B](#fig3s2){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.22441.011](10.7554/eLife.22441.011)10.7554/eLife.22441.012Figure 3---figure supplement 1.The knock-in design of *trpA1*Gal4*^CP2A^*.By CRISPR/Cas9-induced homologous recombination, Gal4 is inserted into the shared C terminal of *trpA1* isoforms right before the stop codon. The knock-in could result in bi-cistronic transcripts expressing both TRPA1 and Gal4.**DOI:** [http://dx.doi.org/10.7554/eLife.22441.012](10.7554/eLife.22441.012)10.7554/eLife.22441.013Figure 3---figure supplement 2.Additional evidence for *trpA1* expression and function in ISCs.(**A**) RT-qPCR measurement of midguts expressing the cell death gene *rpr* in ISCs for 4d for the expression of *esg*, *trpA1* (using primers for *CD* isoforms), EC marker *ε-Trpsin* (*εTrp*), *Pdm1*, or *pros. GAPDH* and *rp49* are used for normalization. The data are presented as mean ± SEM for three technical replicates. We repeated the experiments (two biological replicates) and observed consistent results. (**B**) Mitosis quantification of midguts expressing *Luc* RNAi or *trpA1* RNAi in self-renewing ISCs (DlGal4ts), differentiating ISCs or enteroblasts (Su(H)Gal4ts), muscles (24BGal4ts), or ubiquitously (tubGal4ts) for 9d, with last 2d feeding bleomycin. DlGal4ts and Su(H)Gal4ts are used to drive gene expression in ISCs and enteroblasts, respectively ([@bib79]). Data are represented as mean ± SEM.**DOI:** [http://dx.doi.org/10.7554/eLife.22441.013](10.7554/eLife.22441.013)

RyR appears to be ubiquitously expressed at low levels in the midgut epithelium, based on the expression pattern of *RyRGal4^R14G09^* ([Figure 3D](#fig3){ref-type="fig"}), where Gal4 is under the control of 2.92 kb putative enhancer region sequence of *RyR* ([@bib54]).

TRPA1-D in the midgut senses the oxidative stress associated with tissue damage {#s2-3}
-------------------------------------------------------------------------------

Oxidative stress has previously been observed in tissue damage conditions involving JNK activation ([@bib27]) and pathogen infection ([@bib23]; [@bib40]). The source of oxidative stress is generally attributed to an imbalance in the formation of ROS and impaired antioxidant machinery in unhealthy tissues ([@bib27]; [@bib42]). Staining with dihydro-ethidium (DHE) ([@bib51]) confirmed that ROS levels in the midgut increase following tissue damage induced by feeding flies with paraquat ([Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}), a widely used oxidant that interferes with electron transfer to catalyze formation of superoxide-free radicals ([@bib7]), or bleomycin ([Figure 4---figure supplement 1C](#fig4s1){ref-type="fig"}), a chemotherapy drug that cleaves DNA via an unresolved mechanism potentially related to ROS production ([@bib26]). In addition, induction of midgut stress by JNK pathway activation or massive EC apoptosis by *rpr* expression can also lead to increased ROS and ISC expansion ([Figure 4---figure supplement 1F--J](#fig4s1){ref-type="fig"}).

Both TRPA1 and RyR are associated with redox sensing ([@bib22]; [@bib24]; [@bib68]). Guntur et al. found that TRPA1-C and TRPA1-D isoforms are H~2~O~2~-sensitive and that their endogenous expressions in the ring gland, or ectopic expression in other tissues, confer UV light sensitivity via sensing UV light-induced H~2~O~2~ production. To directly measure whether gut-specific TRPA1 isoforms can respond to paraquat, we used two-electrode voltage clamp recordings to measure the channel activities of TRPA1-C and -D ([@bib73]). In this experiment, we expressed similar amount of mRNA for TRPA1-C or -D isoform in the *Xenopus* oocytes, clamped the membrane potential at −80 mV, and measured the current flowing through the ion channels in the oocyte membrane. The current value is proportional to the opening probability of the ion channels. We added paraquat and AITC (used as the positive control) into the bath solution of oocytes sequentially to trigger the opening of the TRPA1-C or -D channel and compare their strength and dynamics. TRPA1-C barely displayed any response to paraquat ([Figure 4A](#fig4){ref-type="fig"}), whereas expression of TRPA1-D induced a slow increase in current ([Figure 4B](#fig4){ref-type="fig"}). Consistently, overexpression of TRPA1-D, but not TRPA1-C, stimulated ISCs expressing *trpA1* RNAi to proliferate in response to paraquat ([Figure 3C--F](#fig3){ref-type="fig"}).10.7554/eLife.22441.014Figure 4.TRPA1 can respond to oxidant agent and its activation stimulates ISC activity.(**A--B**) Oocyte clamp measurement of TRPA1-C or TRPA1-D channel activities in response to paraquat. The same amounts of mRNAs for TRPA1-C or TRPA1-D were injected into Xenopus oocytes. 4 mM paraquat is present in the buffer during the period marked with the gray line on the top. Near the end of the experiment, the TRPA1 agonist AITC was added as a positive control (indicated with arrowhead). 2 mM and 10 mM paraquat were also tested and gave consistent results. (**C--E**) Midguts, expressing *trpA1* RNAi alone, or together with TRPA1-C or TRPA1-D in the ISCs for 7d, with the last 2d feeding paraquat (**C'--E'**), are stained for the mitosis marker pH3. Nucleus-localized GFP (nlsGFP) is used as the control for transgenic expression. We have also tested UAS-ultraGFP ([@bib78]) that consists of multiple copies of UAS-2xEGFP as control and obtained the same results as UAS-nlsGFP with regard to stem cell activity (except that ultraGFP reporter is much brighter than nlsGFP). (**F**) Mitosis quantification of midguts expressing *trpA1* RNAi together with TRPA1-C or TRPA1-D under normal and paraquat-feeding conditions. N \> 4 midguts per genotype per treatment are analyzed for quantification. UAS-ultraGFP is used as the control for transgenic expression. Data are represented as mean ± SEM. Note that TRPA1-C or TRPA1-D are still targeted by *trpA1* RNAi, which might limit their capacity to rescue *trpA1* RNAi. (**G**) Mitosis quantification of midguts expressing *CncC* RNAi alone, or together with *trpA1* RNAi in the ISCs for 7d. N \> 7 midguts are analyzed for each genotype. Data are represented as mean ± SEM. (**J**) Mitosis quantification of midguts overexpressing TRPA1-C, TRPA1-D, or TRPA1-A in ISCs for 7d. N \> 5 midguts per genotype are analyzed. Data are represented as mean ± SEM.**DOI:** [http://dx.doi.org/10.7554/eLife.22441.014](10.7554/eLife.22441.014)10.7554/eLife.22441.015Figure 4---source data 1.Complete results for [Figure 4F--H](#fig4){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.22441.015](10.7554/eLife.22441.015)10.7554/eLife.22441.016Figure 4---figure supplement 1.Elevated ROS is a common stress signal in various midgut damage conditions.(**A--E**) Dihydro-ethidium (DHE) stainings of live midguts expressing GFP in ISCs for 3d from flies fed with normal food, food containing 2 mM paraquat, 25 µg/ml bleomycin for 6 hr, pathogens *Pseudomonas entomophila* (P.e.), or *Pseudomonas aeruginosa* (PA14) for 18 hr. DHE signal channel is shown below the merged image. The control group for *Pseudomonas* infection, using Bacteria-free LB media, is not shown in the figure because the midgut DHE staining looks the same as flies fed with normal food. Arrowheads highlight examples of stem cells that have high ROS concentration. (**F--G**) DHE staining of midguts overexpressing active JNKK (*Drosophila* Hep^ca^) for 1d in ISCs with EGT. (**H--J**) DHE staining of midguts overexpressing Hep^ca^ or cell death gene *reaper* (*rpr*) for 2d in ECs with MyO1AGal4ts. esgGFP labels the ISCs.**DOI:** [http://dx.doi.org/10.7554/eLife.22441.016](10.7554/eLife.22441.016)

Previously, it has been reported that knockdown of antioxidant protein CncC in ISCs can induce mitosis ([@bib27]). Our observation that *trpA1* RNAi suppresses the hyper-proliferation status induced by CncC RNAi ([Figure 4G](#fig4){ref-type="fig"}) places TRPA1 genetically downstream of the pathway controlling ROS for ISC proliferation. Further, overexpression of TRPA1-D or conventional TRPA1-A isoform (active at 29°C) in stem cells can induce mitosis significantly, suggesting that increased TRPA1-calcium signaling is sufficient to drive ISC proliferation ([Figure 4H](#fig4){ref-type="fig"}).

TRPA1 and RyR are required for normal and ROS-induced cytosolic Ca^2+^ levels in ISCs {#s2-4}
-------------------------------------------------------------------------------------

Interestingly, TRPA1 and RyR are not critically required in the midgut epithelium for development, because flies expressing *trpA1* RNAi or *RyR* RNAi with esgGal4 throughout development \[that is, in adult midgut progenitors (AMPs) during larval stages and in adults ISCs, see ([@bib31]) can survive to adulthood without gross defects when they are fed with normal food\]. For young adult flies of these genotypes, we used the ultrasensitive GCaMP6s fluorescent reporter ([@bib9]) to examine cytosolic Ca^2+^ concentrations in their ISCs. While the number of GFP+ (i.e. high cytosolic Ca^2+^ concentration) ISCs in wild-type midguts increases significantly 10 min after adding paraquat to a final concentration of 4 mM ([Figure 5A, A' and D](#fig5){ref-type="fig"}), expression of *trpA1* RNAi or *RyR* RNAi in ISCs (driven by esgGal4 throughout development) not only reduced the basal levels of cytosolic Ca^2+^ in stem cells ([Figure 5A--C](#fig5){ref-type="fig"}) but also inhibited the ROS-mediated increase in cytosolic Ca^2+^ ([Figure 5A'--C'](#fig5){ref-type="fig"}). The observed reduction of high Ca^2+^ ISCs is not due to decrease in the total number of ISCs, as total ISC number or density in young adult flies is not yet significantly affected by *trpA1* RNAi or *RyR* RNAi ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}).10.7554/eLife.22441.017Figure 5.TRPA1 and RyR are required for ROS-mediated Ca^2+^ increases in ISCs.(**A--C**) Imaging of midguts expressing the GCaMP6s reporter alone or together with *trpA1* RNAi or *RyR* RNAi in ISCs. The same guts are imaged again after exposure to 4 mM paraquat in the imaging buffer for 10 min (**A'--C'**). The images are acquired on a Keyence microscope. (**D**) Quantification of high Ca^2+^ (GFP+) stem cells within the posterior midgut region. N \> 5 midguts are analyzed for each genotype. Data are represented as mean ± SEM. (**E--G**) Numeric kinetics of high Ca^2+^ stem cells in midguts expressing *trpA1* RNAi or *RyR* RNAi in ISCs. Wild-type midguts expressing GCaMP6s alone serve as control. Time-lapse confocal imaging is used for the analysis (see Supplementary Movies). The average number of high Ca^2+^ stem cells before drug treatment is set as the basal level of 0 for individual imaging experiments. Final concentration of 4 mM paraquat (**E**), 0.03% AITC (**F**), 4 µM thapsigargin (**G**) are added at 150 s. At least three replicates of each genotypes/treatments are shown in the figure, with different colors labeling different genotypes.**DOI:** [http://dx.doi.org/10.7554/eLife.22441.017](10.7554/eLife.22441.017)10.7554/eLife.22441.018Figure 5---source data 1.Results for [Figure 5D](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1D--E](#fig5s1){ref-type="fig"}, [Figure 5---figure supplement 2F](#fig5s2){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.22441.018](10.7554/eLife.22441.018)10.7554/eLife.22441.019Figure 5---figure supplement 1.The total number of ISCs expressing esgGal4\>GCamP6s reporter is not significantly reduced by *trpA1* RNAi or *RyR* RNAi.(**A--C**) Anti-GFP staining of midguts expressing GCamP6s alone, or together with *trpA1* RNAi or *RyR* RNAi in ISCs detects GCamP6s expression. The images are acquired on a confocal microscope. The relative density of GCamP6s+ (driven by esgGal4) cells, imaged on a Keyence microscope covering most of the posterior midgut region, is quantified in (**D**) while the total number of GCamP6s+ cells in the posterior midgut region is quantified in (**E**). N \> 8 midguts are analyzed for each genotype. Data are represented as mean ± SEM.**DOI:** [http://dx.doi.org/10.7554/eLife.22441.019](10.7554/eLife.22441.019)10.7554/eLife.22441.020Figure 5---figure supplement 2.Additional reporters showing that TRPA1 and RyR are required for ROS-mediated Ca^2+^ increases in ISCs.(**A--B**) Confocal calcium imaging of midguts that express bi-cistronic UAS-tdTomato-P2A-GCaMP5G reporter alone or together with *trpA1* RNAi in ISCs with exposure to 2 mM paraquat for 5 min (**A'--B'**). The bi-cistronic reporter consists of tdTomato that labels all cells expressing the reporter, and GCaMP5G whose GFP signal intensity reflects intracellular calcium concentration ([@bib12]). (**C--E**) Midguts expressing the TRIC lexGFP calcium reporter alone or together with *trpA1* RNAi or *RyR* RNAi in ISCs for 6d, with the last 1d feeding 2 mM paraquat (**C'--E'**) are stained to examine stem cell Ca^2+^ concentration in vivo. The conventional *UAS*-RFP reporter is used to label all stem cells. (**F**) Quantification of high Ca^2+^ stem cells (GFP+) ratio to all stem cells (RFP+) for midguts in experiments (**C--E**). N = 16, 10, six images are analyzed for the genotypes of control, *trpA1* RNAi, and *RyR* RNAi (half feeding normally, half feeding paraquat for 1d). Data are represented as mean ± SEM.**DOI:** [http://dx.doi.org/10.7554/eLife.22441.020](10.7554/eLife.22441.020)

Defining the average number of high Ca^2+^ stem cells before drug treatment as a baseline, we used the confocal time-lapse GCaMP6s imaging ([Videos 1](#media1){ref-type="other"}--[6](#media6){ref-type="other"}) and analysis to identify the kinetics of high Ca^2+^ in stem cells. Consistent with the TRPA1 channel kinetics as measured in the voltage clamp experiments in oocytes ([Figure 4A--B](#fig4){ref-type="fig"}), treatment with 4 mM paraquat caused a slow and continuous increase in the average number of high Ca^2+^ ISCs ([Figure 5E](#fig5){ref-type="fig"}), whereas the TRPA1 agonist AITC triggered a sharp increase followed by a quick drop in the number of high Ca^2+^ ISCs ([Figure 5F](#fig5){ref-type="fig"}). Finally, responses to both paraquat and AITC were dependent on TRPA1 and RyR ([Figure 5E--F](#fig5){ref-type="fig"}), whereas treatment with the SERCA inhibitor thapsigargin, as a positive control, led to increased Ca^2+^ in ISCs expressing *trpA1* RNAi or *RyR* RNAi ([Figure 5G](#fig5){ref-type="fig"}).Video 1.Calcium imaging of ISCs in response to paraquat.Midguts expressing GCaMP6s reporter in ISCs are dissected and imaged in adult hemolymph-like (AHL) buffer. Z-stack images were acquired with 10 s interval. A maximal intensity z-projection was shown in the movie. A final concentration of 4 mM oxidant agent paraquat was added at 150 s (the 15th frame of the movie).**DOI:** [http://dx.doi.org/10.7554/eLife.22441.021](10.7554/eLife.22441.021)10.7554/eLife.22441.021Video 2.Calcium imaging of ISCs expressing *trpA1* RNAi in response to paraquat.Midguts expressing GCaMP6s reporter together with *trpA1* RNAi in ISCs were dissected and imaged in AHL buffer. Z-stack images were acquired with 10 s interval. A maximal intensity z-projection was shown in the movie. A final concentration of 4 mM oxidant agent paraquat was added at 150 s (the 15th frame of the movie).**DOI:** [http://dx.doi.org/10.7554/eLife.22441.022](10.7554/eLife.22441.022)10.7554/eLife.22441.022Video 3.Calcium imaging of ISCs expressing *RyR* RNAi in response to paraquat.Midguts expressing GCaMP6s reporter together with *RyR* RNAi in ISCs were dissected and imaged in AHL buffer. Z-stack images were acquired with 10 s interval. A maximal intensity z-projection was shown in the movie. A final concentration of 4 mM oxidant agent paraquat was added at 150 s (the 15th frame of the movie).**DOI:** [http://dx.doi.org/10.7554/eLife.22441.023](10.7554/eLife.22441.023)10.7554/eLife.22441.023Video 4.Calcium imaging of ISCs in response to AITC.Midguts expressing GCaMP6s reporter in ISCs are dissected and imaged in AHL buffer. Z-stack images were acquired with 10 s interval. A maximal intensity z-projection was shown in the movie. A final concentration of 0.03% TRPA1 agonist AITC was added at 150 s (the 15th frame of the movie).**DOI:** [http://dx.doi.org/10.7554/eLife.22441.024](10.7554/eLife.22441.024)10.7554/eLife.22441.024Video 5.Calcium imaging of ISCs expressing *trpA1* RNAi in response to AITC.Midguts expressing GCaMP6s reporter together with *trpA1* RNAi in ISCs were dissected and imaged in AHL buffer. Z-stack images were acquired with 10 s interval. A maximal intensity z-projection was shown in the movie. A final concentration of 0.03% TRPA1 agonist AITC was added at 150 s (the 15th frame of the movie).**DOI:** [http://dx.doi.org/10.7554/eLife.22441.025](10.7554/eLife.22441.025)10.7554/eLife.22441.025Video 6.Calcium imaging of ISCs expressing *RyR* RNAi in response to AITC.Midguts expressing GCaMP6s reporter together with *RyR* RNAi in ISCs were dissected and imaged in AHL buffer. Z-stack images were acquired with 10 s interval. A maximal intensity z-projection was shown in the movie. A final concentration of 0.03% TRPA1 agonist AITC was added at 150 s (the 15th frame of the movie).**DOI:** [http://dx.doi.org/10.7554/eLife.22441.026](10.7554/eLife.22441.026)10.7554/eLife.22441.026

Using GCaMP5G as the Ca^2+^ reporter and tdTomato as an internal control, we found that *trpA1* RNAi blocked the increase of cytosolic Ca^2+^ following treatment with 2 mM paraquat ([Figure 5---figure supplement 2A,A', B,B'](#fig5s2){ref-type="fig"}). Similar results were observed with another reporter GCaMP6f (data not shown).

In addition, we used TRIC (transcriptional reporter of intracellular Ca^2+^) ([@bib20]) to examine cytosolic Ca^2+^ concentration in ISCs in vivo on fixed midguts. With TRIC lexGFP and a conventional UAS-RFP reporter, we found that the percentage of high Ca^2+^ ISCs among all stem cells increased from 23% to 63% ([Figure 5---figure supplement 2C,C', F](#fig5s2){ref-type="fig"}) when flies were fed 2 mM paraquat for 1 day. In adult midguts expressing *trpA1* RNAi or *RyR* RNAi in adult ISCs for 6 days, high Ca^2+^ ISCs showed little, if any, increase following paraquat feeding ([Figure 5---figure supplement 2D,D', E,E', F](#fig5s2){ref-type="fig"}). Unlike GCamP reporters, a reduction in basal levels of high Ca^2+^ ISCs by *trpA1* RNAi or *RyR* RNAi was not observed with TRIC reporter, which might be due to differences in the stability and detection threshold of reporters as well as the time frame of knockdown for the two sets of experiments.

Cytosolic Ca^2+^ induces Ras/MAPK activity {#s2-5}
------------------------------------------

The biological functions of TRPA1, RyR, and cytosolic Ca^2+^ signaling have been extensively studied in neurons, where it has been established that membrane depolarization and Ca^2+^ influx can activate Ras/MAPK ([@bib57]; [@bib60]). Thus, we next asked whether high Ca^2+^ in ISCs similarly activates Ras/MAPK. To do this, we stained midguts with antibodies against diphospho-extracellular signal-regulated kinase (dpErk), which is a measure of *Drosophila* Ras/MAPK activity ([@bib18]). Adult midguts expressing *SERCA* RNAi in ISCs for 2 days, which at that stage do not present signs of ISCs expansion, showed induced MAPK activity ([Figure 6A--B](#fig6){ref-type="fig"}), and expression of *trpA1* RNAi ([Figure 6C](#fig6){ref-type="fig"}) or *RyR* RNAi ([Figure 6D](#fig6){ref-type="fig"}) decreased the levels of MAPK activity. Consistent with our observation that ISC Ca^2+^ induction by SERCA inhibition does not depend on *trpA1* or *RyR* ([Figure 5G](#fig5){ref-type="fig"}), *SERCA* RNAi could override *trpA1* RNAi ([Figure 6G](#fig6){ref-type="fig"}) or *RyR* RNAi ([Figure 6H](#fig6){ref-type="fig"}) to activate MAPK. To test whether the increased dpErk signal we observed with *SERCA* RNAi merely reflects an hyper-proliferative status for ISCs, we combined *SERCA* RNAi with knockdown of *Yorkie* (*Yki*), the Hippo pathway transcriptional factor required for damage-induced ISC proliferation ([@bib36]; [@bib58]; [@bib62]; [@bib66]). Although *Yki* RNAi could inhibit ISC proliferation caused by *SERCA* RNAi ([Figure 7---figure supplement 1F--G](#fig7s1){ref-type="fig"}), it could not block MAPK activity ([Figure 6F](#fig6){ref-type="fig"}). On the other hand, *Ras1* (*Drosophila Ras*) RNAi could block *SERCA* RNAi-induced MAPK activity ([Figure 6E](#fig6){ref-type="fig"}). Altogether, our data suggest that Ras/MAPK activity is likely the direct target of high cytosolic Ca^2+^ in ISCs, rather than the consequence of cross-activation by other proliferation-related pathways such as Yki.10.7554/eLife.22441.027Figure 6.High cytosolic Ca^2+^ is necessary and sufficient to activate Ras/MAPK in ISCs.(**A--D**) Midguts expressing *Luc* RNAi, *SERCA* RNAi, *trpA1* RNAi, or *RyR* RNAi in ISCs for 2-3d are stained for the Ras/MAPK activity marker dpErk. The channel of dpErk signal is shown below the merged image. Note *trpA1* RNAi group was imaged on a different date, but alongside *Luc* RNAi which exhibited the same level of pErk signal as the control group presented in A. (**E--H**) Midguts expressing *SERCA* RNAi together with *Ras1* RNAi, *Yki* RNAi, *trpA1* RNAi, or *RyR* RNAi in ISCs for 3d are stained for dpErk. The channel of dpErk signal is shown below the merged image. Note *trpA1* RNAi group in G was imaged on a different date together with C. (**I--J**) Midguts expressing the TRIC lexGFP reporter of intracellular calcium concentration and *Luc* RNAi or *trpA1* RNAi Luc in ISCs for 5d, with the last 2d feeding paraquat (**I'--J'**), are stained for dpErk. The channel of dpErk signal is shown to the right of the merged image. The TRIC lexGFP reporter consists of lexop-GFP, and two split modules of lexA whose assembly is dependent on intracellular calcium concentration.**DOI:** [http://dx.doi.org/10.7554/eLife.22441.027](10.7554/eLife.22441.027)10.7554/eLife.22441.028Figure 6---source data 1.Complete results for [Figure 6---figure supplement 2H--I](#fig6s2){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.22441.028](10.7554/eLife.22441.028)10.7554/eLife.22441.029Figure 6---figure supplement 1.Prolonged induction of high cytosolic Ca^2+^ in ISCs results in a nonspecific and variable pattern of Ras/MAPK activation.(**A--C**) Midguts expressing *SERCA* RNAi together with *Luc* RNAi, *Ras1* RNAi, or *Yki* RNAi in ISCs for 5d are stained for dpErk. The channel of dpErk signal is shown below the merged image. A and A' are biological replicates of the same genotype showing examples of variation. Although pErk induction is still detectable in some ISCs, the signal intensity varies among different ISCs and different midguts.**DOI:** [http://dx.doi.org/10.7554/eLife.22441.029](10.7554/eLife.22441.029)10.7554/eLife.22441.030Figure 6---figure supplement 2.Src might be a mechanism by which cytosolic Ca^2+^ can activate Ras/MAPK in ISCs.(**A--D**) Midguts expressing the constitutive active form of Src42A (Src42A^ca^), Src64B, or Ras1^A^ in ISCs for 2d are stained for the Ras/MAPK activity marker dpErk. The channel of dpErk signal is shown below the merged image. *w-* genetic background is used as the control for transgenic expression. (**E--G**) Midguts expressing *trpA1* RNAi alone or together with Src42A^ca^/ Src64B in ISCs for 2d are stained for dpErk. The channel of dpErk signal is shown below the merged image. (**H**) Mitosis quantification of midguts expressing *trpA1* RNAi with GFP, Src42A^ca^, or Src64B in ISCs for 3d. N \> 5 midguts are analyzed for each genotype. Data are represented as mean ± SEM. (**I**) Mitosis quantification of midguts expressing *SERCA* RNAi with *Luc* RNAi, *Src42A* RNAi, or *Src64B* RNAi in ISCs for 4d. N \> 4 midguts are analyzed for each genotype. Data are represented as mean ± SEM.**DOI:** [http://dx.doi.org/10.7554/eLife.22441.030](10.7554/eLife.22441.030)

To further examine the relationship between Ca^2+^ levels and MAPK activity, we performed dpErk staining of midguts expressing the TRIC reporter in ISCs. Paraquat feeding for 1 day led to an increase in the number of cells with high dpErk signals, a majority of which are high Ca^2+^ ISCs ([Figure 6I,I'](#fig6){ref-type="fig"}). Moreover, paraquat induction of MAPK activity appears to require high Ca^2+^ in ISCs, because such response could be inhibited by *trpA1* RNAi expression in ISCs ([Figure 6J,J'](#fig6){ref-type="fig"}). It should be noted that the best timing to detect autonomous activation of dpErk by high Ca^2+^ in the ISCs is before they enter the hyper-proliferative stage. Once ISCs start to expand massively following prolonged high Ca^2+^ induction, pErk returns to normal levels in many ISCs and is non-autonomously induced in some ECs, resulting in a diffusive activation pattern ([Figure 6---figure supplement 1A--C](#fig6s1){ref-type="fig"}).

In neurons, a common mechanism by which Ca^2+^ regulates Ras/MAPK is through Ca^2+^-sensitive Src kinases ([@bib11]), in a process faster than any transcriptional response ([@bib56]; [@bib60]). Interestingly, overexpression of Src (Src42A or Src64B in *Drosophila*) in ISCs triggers ectopic MAPK activation and proliferation ([Figure 6---figure supplement 2A--C](#fig6s2){ref-type="fig"}), even in the presence of *trpA1* RNAi ([Figure 6---figure supplement 2E--H](#fig6s2){ref-type="fig"}). Moreover, we could observe significant inhibition of *SERCA* RNAi-induced ISC proliferation by *Src64B* RNAi ([Figure 6---figure supplement 2I](#fig6s2){ref-type="fig"}) despite the likelihood of functional redundancy between Src64B and Src42A ([@bib44]; [@bib69]). These data suggest that Src might mediate the activation of Ras/MAPK by cytosolic Ca^2+^ in ISCs.

Ras/MAPK activity is the major effector of cytosolic calcium for ISC proliferation {#s2-6}
----------------------------------------------------------------------------------

As a universal intracellular signal, increased Ca^2+^ might trigger a wide range of responses. Consistent with previous results ([@bib13]; [@bib32]), ISCs expressing the active forms of many Ca^2+^ effector proteins, such as Ras1, Raf, phosphatase Calcineurin A1 (CanA1), CREB-regulated transcriptional co-activator (CRTC), and cyclic-AMP response element binding protein B (CrebB), displayed an hyper-proliferation phenotype ([Figure 7A--E](#fig7){ref-type="fig"}). To determine which Ca^2+^ effector proteins are sufficient for Ca^2+^-induced ISC proliferation, we expressed *trpA1* RNAi in ISCs together with each putative Ca^2+^ effector protein. Strikingly, MAPK activation via expression of active Ras1 (Ras1^A^), constitutively active Raf (Raf^gof^), or secreted form of *spi* is epistatic to *trpA1* RNAi for ISCs proliferation ([Figure 7A--B and A'--B', 7F](#fig7){ref-type="fig"}). Consistently, MAPK activation is epistatic to *RyR* RNAi ([Figure 7---figure supplement 3](#fig7s3){ref-type="fig"}). By contrast, *trpA1* RNAi effectively blocked the mitogenic activity of constitutively active CanA1 (CanA1^ca^) ([@bib14]), CRTC ([@bib37]), or active CrebB (CrebB^act^) ([@bib19]) ([Figure 7C--E and C'--E', F](#fig7){ref-type="fig"}). Furthermore, while *Ras1* RNAi could suppress *SERCA* RNAi-induced ISC proliferation, neither *CanA1* RNAi nor *CrebB* RNAi could ([Figure 7---figure supplement 1C--G](#fig7s1){ref-type="fig"}), and *CRTC* RNAi could only confer moderate suppression of ISC hyper-proliferation ([Figure 7---figure supplement 1E--F](#fig7s1){ref-type="fig"}). Results of these genetic epistasis analyses, together with examination of changes in pErk signal intensity ([Figure 6](#fig6){ref-type="fig"}), indicate that MAPK activity is both necessary and sufficient for high Ca^2+^-triggered ISC proliferation.10.7554/eLife.22441.031Figure 7.Ras/MAPK activity, not CanA/CRTC/CrebB, is sufficient for ISC proliferation in the absence of TRPA1.(**A--E**) Midguts over-expressing calcium responsive signaling molecules such as active Ras1 (Ras1A), constitutively active Calcineurin A1 (CanA1^ca^), CREB-regulated transcription coactivator (CRTC), or active form of Creb (Creb^act^) in ISCs for 5d are stained for the mitosis marker pH3. The expansion of esg\>GFP signal by CanA1^ca^ is reduced by *trpA1* RNAi, although not quite down to the wild-type level. This could be due to the different kinetics of two reagents, as CanA1^ca^ may take effect sooner than *trpA1* RNAi. (**A'--E'**) Midguts expressing *trpA1* RNAi together with calcium-responsive signaling molecules in ISCs for 5d are stained for the mitosis marker pH3. (**F**) Mitosis quantification of midguts expressing GFP, Ras/ Raf, RTK ligands Spi/ Pvf1, CanA1^ca^, CRTC, Creb^act^, alone or together with *trpA1* RNAi for genetic epistasis analysis. N \> 5 midguts are analyzed for each genotype. Data are represented as mean ± SEM. Although it has been reported that *pvf1* overexpression can increase ISC population ([@bib5]), we could barely detect mitotic effect of Pvf1 in young adult flies.**DOI:** [http://dx.doi.org/10.7554/eLife.22441.031](10.7554/eLife.22441.031)10.7554/eLife.22441.032Figure 7---source data 1.Complete results for [Figure 7F](#fig7){ref-type="fig"}, [Figure 7---figure supplement 1F--G](#fig7s1){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.22441.032](10.7554/eLife.22441.032)10.7554/eLife.22441.033Figure 7---figure supplement 1.Ras/MAPK activity, but not CanA1/CrebB, is required for ISC proliferation induced by calcium influx.(**A--E**) Midguts expressing *SERCA* RNAi together with *Luc* RNAi, *EGFR* RNAi, *CanA1* RNAi, *CrebB* RNAi, or *CRTC* RNAi in ISCs for 3d are stained for mitosis marker pH3. (**F**) Mitosis quantification of midguts expressing *SERCA* RNAi together with *Luc* RNAi, *EGFR* RNAi (three different lines), *Ras1* RNAi, *Yki* RNAi, *CanA1* RNAi, *CrebB* RNAi (two different lines), or *CRTC* RNAi in ISCs for 5d. N \> 7 midguts are analyzed for each genotype. Data are represented as mean ± SEM. (**G**) Mitosis quantification of midguts expressing *SERCA* RNAi^2^ alone, or together with *CanA1* RNAi^fb5^, or *Yki* RNAi^v^ in ISCs for 5d. N \> 5 midguts are analyzed for each genotype. Data are represented as mean ± SEM. For *CanA1* RNAi line 'fb5', flies with a similar w- genetic background carrying an empty insertional landing site (v60100) are used as the control (Ctrl^v^). (**H**) RT-qPCR measurement of *CRTC* expression in midguts ubiquitously expressing *Luc* RNAi or *CRTC* RNAi for 5d. *GAPDH* and *rp49* are used for normalization. The data are presented as mean ± SEM for three technical replicates. (**I**) RT-qPCR measurement of *CanA1* RNAi ^fb5^ knockdown efficiency. L3 larvae expressing RNAi for 2 days are used for better quantification because midgut *CanA1* expression is barely detectable. *GAPDH* and *rp49* are used for normalization. The data are presented as mean ± SEM for three technical replicates.**DOI:** [http://dx.doi.org/10.7554/eLife.22441.033](10.7554/eLife.22441.033)10.7554/eLife.22441.034Figure 7---figure supplement 2.Ligands for receptor tyrosine kinases (RTKs) are affected by cytosolic Ca^2+^ signaling.(**A**) RT-qPCR measurement of midguts expressing *Luc* RNAi or *trpA1* RNAi in ISCs for 6d, with the last day feeding on normal food or paraquat. *rp49* is used for normalization. The data are presented as mean ± SEM for three technical replicates. While expression of JAK/ Stat pathway ligands *upd1* and *upd2* remains unaffected, multiple RTK ligands (*spi*, *krn*, *vn*, *pvf1*, *pvf3*, *dilp3*, highlighted by gray square boxes) are down-regulated by *trpA1* RNAi. (**B**) RT-qPCR measurement of midguts expressing *Luc* RNAi or *trpA1* RNAi in ISCs for 9d, with the last 2d feeding on normal food or paraquat. *rp49* is used for normalization. The data are presented as mean ± SEM for three technical replicates. Note that only *spi*, *pvf1*, and *dilp3* are consistently down-regulated in *trpA1* RNAi groups in both (**A**) and (**B**). Different trends of *krn*, *vn*, and *pvf3* expression observed in (**B**) compared to (**A**) might suggest a delay, rather than reduction of these ligands by *trpA1* RNAi. (**C**) RT-qPCR measurement of midguts expressing *Luc* RNAi or *SERCA* RNAi in ISCs for 1d. Such early time point is chosen empirically to allow for efficient knockdown and avoid confounding effects of signaling pathway cross-activation at later stages of ISC proliferation. *rp49* is used for normalization. The data are presented as mean ± SEM for three technical replicates.**DOI:** [http://dx.doi.org/10.7554/eLife.22441.034](10.7554/eLife.22441.034)10.7554/eLife.22441.035Figure 7---figure supplement 3.Ras/MAPK activity is sufficient for ISC proliferation in the absence of RyR.(**A--B**) Midguts, expressing *RyR* RNAi alone, or together with *SERCA* RNAi in ISCs for 5d, are stained for mitosis marker pH3.**DOI:** [http://dx.doi.org/10.7554/eLife.22441.035](10.7554/eLife.22441.035)

Previous studies have documented that receptor tyrosine kinase (RTK) EGFR is required for MAPK activity and ISC proliferation ([@bib32]). We found that *EGFR* RNAi completely inhibited ISCs proliferation caused by *SERCA* RNAi ([Figure 7---figure supplement 1B,F](#fig7s1){ref-type="fig"}), indicating that MAPK activation by Ca^2+^ requires EGFR signaling. Interestingly, as transcriptional regulation of ligands and receptors by their own pathways is commonly observed (see for example [@bib3]), we examined by RT-qPCR the expression of EGFR ligands, as well as other RTK ligands, in midguts with cytosolic Ca^2+^ levels altered in ISCs. Interestingly, transcription of the EGFR ligand *spi* and the Pvr ligand *pvf1* ([@bib5]) were suppressed by *trpA1* RNAi and up-regulated in midguts expressing *SERCA* RNAi in ISCs for 1 day to mimic early stages of Ca^2+^ induction ([Figure 7---figure supplement 2](#fig7s2){ref-type="fig"}). Altogether, these results suggest that positive RTK signaling feedback loops may play a role in the activation of Ras/MAPK in the context of Ca^2+^ signaling.

Discussion {#s3}
==========

ROS induces ISC proliferation via cation channel-mediated Ca^2+^ signaling {#s3-1}
--------------------------------------------------------------------------

We have found that the two cation channels TRPA1 and RyR are critical for cytosolic Ca^2+^ signaling and ISC proliferation. Under homeostatic conditions, the basal activities of TRPA1 and RyR are required for maintaining cytosolic Ca^2+^ in ISCs to ensure their self-renewal activities and normal tissue turnover ([Figure 8A](#fig8){ref-type="fig"}). Agonists, including but not limited to low levels of ROS, could be responsible for the basal activities of TRPA1 and RyR. Under tissue damage conditions, increased ROS stimulates the channel activities of TRPA1 to mediate increases in cytosolic Ca^2+^ in ISCs ([Figure 8B](#fig8){ref-type="fig"}). As for RyR, besides its potential to directly sense ROS, it is known to act synergistically with TRPA1 in a positive feedback mechanism to release more Ca^2+^ from the ER into the cytosol upon sensing the initial Ca^2+^ influx through TRPA1 ([@bib52]).10.7554/eLife.22441.036Figure 8.Connection between ROS, intracellular calcium, and stem cell activity.(**A**) Under tissue homeostasis conditions, basal levels of ROS and other unidentified stimuli can activate TRPA1 and RyR channels at low levels to allow low levels of cytosolic Ca^2+^, autocrine EGFR ligand Spi, and Ras/MAPK activity required for stem cell self-renewal and minimal level of proliferation. Solid arrows indicate mechanisms that are either well-characterized (green) or demonstrated in this study; dashed arrows indicate unclear mechanisms inferred from literature or this study. (**B**) Under various tissue damage conditions, ROS levels dramatically increase and activate TRPA1, especially the D isoform. RyR channel can be activated either directly by ROS or by the initial Ca^2+^ influx through TRPA1, allowing further calcium release from the ER to the cytosol. High levels of cytosolic Ca^2+^ activate Ras/MAPK signaling via Src, and further amplify Ras/MAPK signaling via autocrine Spi-EGFR signaling. High EGFR-Ras/MAPK activity triggers ISC proliferation.**DOI:** [http://dx.doi.org/10.7554/eLife.22441.036](10.7554/eLife.22441.036)

Our findings on the role of Ca^2+^ signaling for ISC proliferation are consistent with a recent study showing that high levels of cytosolic Ca^2+^ correlate with ISC proliferation, and that a prolonged increase in cytosolic Ca^2+^ concentration is sufficient to trigger ISC proliferation ([@bib13]). Here, we demonstrate that TRPA1 senses damage-induced ROS; that knockdown of *trpA1* or *RyR* efficiently reduces Ca^2+^ induction in the ISCs caused by ROS; and that cytosolic Ca^2+^ induction is required for damage-induced ISC proliferation.

Regulation of cytosolic Ca^2+^ in ISCs {#s3-2}
--------------------------------------

Previously, Deng et al. identified L-glutamate as a signal that can activate metabotropic glutamate receptor (mGluR) in ISCs, which in turn modulates the cytosolic Ca^2+^ oscillation pattern via phospholipase C (PLC) and inositol-1,4,5-trisphosphate (InsP~3~). Interestingly, L-glutamate and *mGluR* RNAi mainly affected the frequency of Ca^2+^ oscillation in ISCs, while their influence on cytosolic Ca^2+^ concentration was very weak. Strikingly, the number of mitotic cells induced by L-glutamate (i.e. an increase from a basal level of \~5 per midgut to \~10 per midgut) is far less than what has been observed in tissue damage conditions (depending on the severity of damage, the number varies from \~20 to more than 100 per midgut following damage) ([@bib2]; [@bib8]; [@bib32]; [@bib36]). Consistent with this, in our screen for regulators of ISC proliferation in response to tissue damage, we tested three RNAi lines targeting *mGluR* (BL25938, BL32872, and BL41668, which was used by Deng et al.), and none blocked the damage response in ISCs, suggesting that L-glutamate and mGluR do not play a major role in damage repair of the gut epithelium.

We find that ROS can trigger Ca^2+^ increases through the redox- sensitive cation channels TRPA1 and RyR under damage conditions. In particular, we demonstrate using voltage-clamp experiments that the TRPA1-D isoform, which is expressed in the midgut, is sensitive to the oxidant agent paraquat. In addition, the results of previous studies have demonstrated the direct response of RyR to oxidants via single channel recording ([@bib70]) and showed that RyR could amplify TRPA1-mediated Ca^2+^ signaling through the Ca^2+^-induced Ca^2+^ release (CICR) mechanism. Interestingly, expression of oxidant- insensitive TRPA1-C isoform in the ISCs also exhibits a tendency to induce ISC proliferation ([Figure 4H](#fig4){ref-type="fig"}), indicating that ROS may not be the only stimuli for TRPA1 and RyR under physiological conditions. Possible other activators in the midgut may be irritant chemicals, noxious thermal/mechanical stimuli, or G-protein-coupled receptors ([@bib17]; [@bib63]; [@bib80]).

Altogether, the concentration of cytosolic Ca^2+^ in ISCs appears to be regulated by a number of mechanisms/inputs including mGluR and the ion channels TRPA1 and RyR. Although mGluR might make a moderate contribution to cytosolic Ca^2+^ in ISCs, TRPA1 and RyR have a much stronger influence on ISC Ca^2+^ levels. Thus, it appears that the extent to which different inputs affect cytosolic Ca^2+^ concentration correlates with the extent of ISC proliferation.

Signaling events downstream of cytosolic Ca^2+^ in ISCs {#s3-3}
-------------------------------------------------------

Although, as a universal intracellular signal, cytosolic Ca^2+^ controls a plethora of cellular processes, we were able to demonstrate that cytosolic Ca^2+^ levels regulate Ras/MAPK activity in ISCs. Specifically, we found that *trpA1* RNAi or *RyR* RNAi block Ras/MAPK activation in stem cells, and that forced cytosolic Ca^2+^ influx by *SERCA* RNAi induces Ras/MAPK activity. Moreover, Ras/MAPK activation is an early event following increases in cytosolic Ca^2+^, since we observed increased dpErk signal in stem cells expressing *SERCA* RNAi before they undergo massive expansion, and when we co-expressed *Yki* RNAi to block proliferation. It should be noted that a more variable pattern of pErk activation was observed with prolonged increases of cytosolic Ca^2+^, suggesting complicated regulations via negative feedback, cross-activation, and cell communication at late stages of Ca^2+^ signaling. This might explain why Deng et al. failed to detect pErk activation after 4 days induction of Ca^2+^ signaling ([@bib13]). Previously, Ras/MAPK activity was reported to increase in ISCs, regulating proliferation rather than differentiation, in regenerating midguts ([@bib32]), which is consistent with our findings about TRPA1 and RyR.

The CanA1/CRTC/CrebB pathway previously proposed to act downstream of mGluR-calcium signaling ([@bib13]) is not likely to play a major role in high Ca^2+^-induced ISC proliferation, as we tested multiple RNAi lines targeting *CanA1* or *CrebB* and none of them suppressed *SERCA* RNAi-induced ISC proliferation. In support of this model, we also found that the active forms of CanA1/ CRTC/ CrebB cannot stimulate mitosis in ISCs when their cytosolic Ca^2+^ levels are restricted by *trpA1* RNAi, whereas mitosis induced by the active forms of Ras or Raf is not suppressed by *trpA1* RNAi.

Cross-talk between Ca^2+^ signaling and EGFR {#s3-4}
--------------------------------------------

Prior to our study, it has been shown that paracrine ligands such as Vn from the visceral muscle, and autocrine ligands such as Spi and Pvf ligands from the stem cells, can stimulate ISC proliferation via RTK-Ras/MAPK signaling ([@bib5]; [@bib32]; [@bib77]). We found that multiple RTK ligands in the midgut are down-regulated by *trpA1* RNAi expression in the ISCs, including *spi* and *pvf1* that can be induced by *SERCA* RNAi. Further, we demonstrated that high Ca^2+^ fails to induce ISC proliferation in the absence of EGFR. As *spi* is induced by EGFR-Ras/MAPK signaling in *Drosophila* cells ([@bib3]), and DNA binding mapping (DamID) analyses from our lab and others indicate that *spi* might be a direct target of transcriptional factors downstream of EGFR-Ras/MAPK in the ISCs ([@bib34]) (Doupé and Perrimon, unpublished), the autocrine ligand Spi might therefore act as a positive feedback mechanism for EGFR-Ras/MAPK signaling in ISCs.

In summary, our study identifies a mechanism by which ISCs sense microenvironment stress signals. The cation channels TRPA1 and RyR detect oxidative stress associated with tissue damage and mediate increases in cytosolic Ca^2+^ in ISCs to amplify and activate EGFR-Ras/MAPK signaling ([Figure 8](#fig8){ref-type="fig"}). In vertebrates, a number of cation channels ([@bib47]), including TRPA1 and RyR ([@bib1]; [@bib6]; [@bib16]), have been associated with tumor malignancy. Our findings, unraveling the relationship between redox-sensing, cytosolic Ca^2+^, and pro-mitosis Ras/MAPK activity in ISCs, could potentially help understand the roles of cation channels in stem cells and cancers, and inspire novel pharmacological interventions to improve stem cell activity for regeneration purposes and suppress tumorigenic growth of stem cells.

Materials and methods {#s4}
=====================

*Drosophila* stocks and culture {#s4-1}
-------------------------------

The following strains were obtained from the Bloomington *Drosophila* Stock Center: *Dl-lacZ* (BL11651)*, y v; attP2* (landing site only, BL36303), *UAS-Luc RNAi* (BL31603), *UAS-trpA1 RNAi* (BL31504, BL31384, BL36780), *UAS-RyR RNAi* (BL29445, BL31540, BL31695), *UAS-SERCA RNAi* (BL25928, BL44581), *trpA1^1^ (BL26504), UAS-trpA1-A* (BL26263, also called *UAS-TrpA1.K*), *UAS-Ras1 RNAi* (BL29319), *UAS-Yki RNAi* (BL31965), *UAS-Src42A RNAi* (BL44039, validated by [@bib65]), *UAS-Src64B RNAi* (BL51772), *UAS-EGFR RNAi* (BL25781, BL31525, BL31526), *UAS-CanA1 RNAi* (BL25850, phenotypically validated by [@bib41]), *UAS-CrebB RNAi* (BL63681, BL29332), *UAS-CRTC RNAi* (BL28886), *UAS-rpr* (BL5823), *UAS-Hep^ca^* (BL6406), *UAS-Src42A^ca^* (BL6410), *UAS-Src64B* (BL8477), *UAS-GCaMP6s* (BL42749), *UAS-GCaMP6f* (BL42747), *UAS-RFP LexAop2-GFP; UAS-MKII::nlsLexA^DBD^, UAS-p65AD::CaM; UAS-p65AD::CaM, tubGal80^ts^* (TRIC lexGFP reporter, BL62828), *tubGal80^ts^* (on the X chromosome, BL7016), *tubGal80^ts^\[10\]* (BL7108), *tubGal80^ts^\[20\]* (BL7019), *tubGal80^ts^\[7\]* (BL7018), *UAS-mCherry* (BL52268)*, UAS-mCherryCAAX* (BL59021), *RyRGal4^R14G09^* (with cloned enhancer region, BL48662), *FRT19A* (BL1744), *FRT42D; FRT82B* (BL8216), *FRT42D w+* (BL1928), *FRT42D; ry^605^* (BL1802), *FRT2A* (BL1997). Strains from Vienna *Drosophila* RNAi Center: *yw; attP* (landing site only, v60100), *UAS-trpA1 RNAi* (v37249) ([@bib80]), *UAS-Ras1 RNAi* (v106642), *UAS-Yki RNAi* (v104523). Strains from Perrimon lab stock: *w1118, UAS-Luciferase, UAS-nlsGFP, UAS-Ras1^A^, UAS-Raf^gof^, esgGal4 UAS-GFP tubGal80^ts^ (EGT), esgGal4, tubGal4, 24BGal4, DaGal4, esgGFP* (generated by David Doupé), *Su(H)GbeGFP* (generated by Li He), *UAS-spi* (secreted form, validated in [@bib21]). *trpA1Gal4^CP2A^* was generated by Junjie Luo. *FRT42D RyR^k04913^* was generated from DGRC111172 (Kyoto Stock Center). *trpA1^1^ FRT2A* and the stock with a deletion of *trpA1*, Df4415, were obtained from C. Montell lab, *DlGal4* and *Su(H)Gal4* from Steven Hou, *UAS-Cas9.P2* from Fillip Port, *UAS-2xEGFP \[m5B29\]; UAS-2xEGFP \[m6B1\] (UAS-ultraGFP)* from Fabio Demontis, *UAS-CncC RNAi* from Dirk Bohmann, *UAS-trpA1-C* (also referred to as *trpA1(A)10b*) and *UAS-trpA1-*D (also referred to as *trpA1(A)10a*) ([@bib22]) from Paul Garrity, *UAS-CanA1 RNAi ^fb5^* and *UAS-CanA1^ca^* (constitutively active) ([@bib75]) from Patrick H. O\'Farrell, *UAS-pvf1* from Edan Foley, *UAS-CRTC* and *UAS-tdTomato-P2A-GCaMP5* from Henri Jasper, *UAS-CrebB^act^* from Jerry Yin. EGT F/O system is from Bruce Edgar: EGT; UAS-Flp, Act\>Stop\>Gal4. For MARCM induction*, hsFlp tubGal80 FRT19A/ FM7; tubGal4 UAS-mCD8::GFP/ TM3* was obtained from Ben Ohlstein, *hsFlp tubGal4 UAS-GFP-myc-nls;; tubGal80 FRT2A/ TM6B* from Gary Struhl, and *yw hsFlp UAS-GFP tubGal4; FRT42D tubGal80* from Huaqi Jiang.

Flies were reared on standard cornmeal/agar medium in 12: 12 light: dark cycles at 25°C unless noted otherwise. Fly food was changed every 2 days to keep fresh. Conditional expression in adult flies using *tubGal80^ts^* was achieved by maintaining flies at 18°C until 4--7 days after eclosion, and then shifting young adults to 29°C. For MARCM experiments, flies were maintained at 18°C until 3--5 days after eclosion, heat-shocked at 37°C for 1 hr, and then maintained back at 18°C before dissection and analysis.

See [Supplementary file 1](#SD8-data){ref-type="supplementary-material"} for detailed genotypes of flies used in each figure.

Infection and compound feeding {#s4-2}
------------------------------

Standard cornmeal/agar medium were melted at 70 \~ 80°C and mixed with a final concentration of 25 µg/ml bleomycin (Calbiochem \#203408) or 2 mM paraquat (Sigma Aldrich \#856177) to prepare food that can induce tissue damage in the fly midgut. For pathogen infection, *Pseudomonas entomophila* (from Tony IP) was grown in LB media at 29°C until reaching OD~600~ = 1, and *Pseudomonas aeruginosa 14* (from Chrysoula Pitsouli) was grown in LB media at 37°C until reaching OD~600~ = 3. Flies were transferred to vials containing a cotton ball impregnated with 5 ml of water solution composed of 20% *Pseudomonas* culture media and 4% sucrose.

RNAi screen for regulators ISC pool size and damage responses {#s4-3}
-------------------------------------------------------------

With a luciferase reporter that we have previously developed as a sensitive surrogate for stem cell pool size ([@bib45]), we performed an RNAi screen to identify novel components regulating ISC activity. In brief, midguts expressing luciferase together with RNAi targeting individual trans-membrane and receptor proteins ([@bib29]) in adult ISCs for 9 days, with the last 2 days feeding either normally or on bleomycin food to induce tissue damage. Ten midguts were collected per genotype/ treatment, snap frozen, and stored at −80°C. After samples from all experiment groups were collected, the midguts were homogenized at 4°C using bead blender in Glo Lysis Buffer (Promega) with Halt protease inhibitor (Pierce 87786) and 2 mM trypsin inhibitor benzamidine. The lysate were centrifuged at 8000 rpm for 5 min to sediment the debris. And the supernatants were measured for luciferase activity using the Steady-Glo luciferase assay system (Promega). Luciferase activities were normalized to the value of spiked-in control groups (*yv; attP2* for TRiP stocks, *v60100* for Vienna stocks, and *w1118* for NIG stocks). In particular, we noticed that *trpA1* RNAi (BL31504), *trpA1* RNAi (v37249), and *RyR RNAi* (BL29445) reduced EGT\>luciferase activity by 74%, 88%, and 80%, respectively under normal feeding condition, and blocked damage-induced EGT\>luciferase expression. We validated the top candidates from the screen by fluorescence imaging.

Staining and fluorescence imaging {#s4-4}
---------------------------------

*Drosophila* midguts were dissected in PBS, fixed in 4% paraformaldehyde PBS solution for 30 min, rinsed and kept for 1 hr in PBST solution (PBS with 0.1% BSA, 0.3% Triton X-100) containing 5% Normal Donkey Serum. Midguts were stained overnight at 4°C with the following primary antibodies in PBST solution: rabbit anti-pH3 (Millipore \#06--570; 1:3000), mouse anti-GFP (Invitrogen A11120; 1:300), rabbit anti-GFP (Invitrogen A6455; 1:500), rabbit anti-RFP (Life Technologies R10367; 1:500), rabbit anti-β-galactosidase (Cappel; 1:6000), rabbit anti-dpErk1/2 (Cell Signaling \#4370; 1:500), rabbit anti-Pdm1 (from Xiaohang Yang; 1:500), rat anti-TRPA1 (from Paul Garrity; 1:100). Fly midguts were then washed three times in PBST and incubated with secondary antibodies and DAPI (1:2000) in PBST for 2 hr in the dark at room temperature. Secondary antibodies were donkey anti-rabbit, anti-mouse, and anti-rat IgGs conjugated to Alexa488, Alexa594 and Alexa647 (used at 1:1000, Molecular Probes). Fly guts were then washed three times in PBST, mounted in Vectashield (Vector Laboratories). For anti-TRPA1 staining, primary antibody incubation was done for 1 day and secondary antibody incubation overnight at 4°C. Images of posterior midgut area were captured with a Zeiss LSM780 confocal microscope equipped with 40x oil lens. A z-stack of 10--20 images covering the epithelium from the apical to the basal side were acquired and shown in max projection. All images were adjusted and assembled using NIH ImageJ.

For counting mitotic cells or MARCM clone size, an epifluorescence microscope was used to examine the stained midguts. For the quantification of esg+, Pros+, Dl+ or Su(H)Gbe+ cell density, as well as GCamP+ cell number, images of the majority of posterior midgut region were acquired on a Keyence microscope.

For measuring midgut length, images of the whole midgut were captured with an epifluorescence microscope. The middle line of the midgut was measured using NIH ImageJ, starting from the end of the proventriculus to the border between the posterior midgut and hindgut, where the malphighian tubules connect to the gut.

For detection of ROS via DHE staining, we followed the previously described protocol ([@bib27]). In brief, midguts were dissected and handled throughout in Schneider's medium (HyClone). After incubation in 30 µM DHE (Invitrogen) for 5 min in the dark at room temperature, midguts were washed three times and mounted in Schneider's medium. Images were captured immediately with a Zeiss LSM780 confocal microscope (543 nm excitation, 550--610 nm detection). All images were adjusted and assembled using NIH ImageJ.

U6-sgRNA for CRISPR/Cas9-mediated conditional knockout {#s4-5}
------------------------------------------------------

Two pairs of short guide RNAs (sgRNAs) targeting the coding region of *trpA1* or *RyR* were designed using the 'Find CRISPRs\' online tool (<http://www.flyrnai.org/crispr2/>) ([@bib28]), and cloned into the double sgRNA vector pCFD4 ([@bib55]) for site- specific insertion into attP2 on the third chromosome. We obtained transgenic flies ubiquitously (driven by U6 promoters) expressing sgRNAs with the following seed sequences:

U6-sg*trpA1*: CACACGATCCACGTCACTGT & CTGTAGACTCCGTTGTAGAG

U6-sg*RyR*: TTCGTGTTCCATCTGTACAA & ACAAGAACGTGCCGCCGGAT

RT-qPCR and *trpA1* isoform analysis {#s4-6}
------------------------------------

Total RNA was extracted from 15 to 20 midguts or 15 heads or 5 larvae (all females) by TRIZOL reagent (Thermo Fisher), converted to cDNA template after DNase I treatment and purification by QIAGEN RNeasy kit. The cDNA was analyzed by real-time quantitative PCR using SYBR Green or by regular PCR (for *trpA1* isoform typing) with *GAPDH* and *rp49* as an internal control. RT-qPCR data were analyzed with Bio-Rad CFX Manager software. Primers used for RT-qPCR or regular PCR (for *trpA1* isoform typing) are shown below:

*trpA1-All*\_FW: AGACGCTCATTAAAGTGCTGA

*trpA1-All*\_RV: AGAAGGACAAGTGGTTCGGT

*trpA1-CD*\_FW: CTTCAGGATATTGCGGGCG

*trpA1-AB*\_FW: GTGGACTATCTGGAGGCGG

*trpA1-AB/CD*\_RV: CCTTCGCATTAAAGTCGCCA

*trpA1-AD*\_FW: TGCCGGCTTTGAATACCATG

*trpA1-BC*\_FW: CTTTGGCCGTGGTGAACA

*trpA1-AD/BC*\_RV: GCCAGGTGAAAGTACTTGCC

*RyR*\_1_FW: GATCGGGACACAGGACATTG

*RyR*\_1_RV: GACAGCTTGTCGTTCGACG

*RyR*\_2_FW: TGCCTGACCATACCGAGTACA

*RyR*\_2_RV: GCCACCAGTCCACTTGGTT

*GAPDH*\_FW: CCAATGTCTCCGTTGTGGA

*GAPDH*\_RV: TCGGTGTAGCCCAGGATT

*rp49*\_FW: ATCGGTTACGGATCGAACAA

*rp49*\_RV: GACAATCTCCTTGCGCTTCT

*esg*\_FW: ATGAGCCGCAGGATTTGTG

*esg*\_RV: CCTCCTCGATGTGTTCATCATCT

*ε-Trypsin*\_FW: TAGACACCGGGATACCTCACATCA

*ε-Trypsin*\_RV: TCCAGCATTCGCGAGATCCGTATT

*Pdm1*\_FW: AGCTGTCCTAACGAGTTCCG

*Pdm1*\_RV: ACATCGCGCATATTTGTGTCAA

*pros*\_FW: TTTGACCGGAGATGGTGACG

*pros*\_RV: GGTCGTTCCTGCCCAGTTTC

*spi*\_FW: CGCCCAAGAATGAAAGAGAG

*spi*\_RV: AGGTATGCTGCTGGTGGAAC

*krn*\_FW: CGTGTTTGGCAACAACAAGT

*krn*\_RV: TGTGGCAATGCAGTTTAAGG

*vn*\_FW: AAGCATCACAAAAGACGTTC

*vn*\_RV: CCGCATCGGAGGAACTATTGA

*pvf1*\_FW: GCGCAGCATCATGAAATCAACCG

*pvf1*\_RV: TGCACGCGGGCATATAGTAGTAG

*pvf2*\_FW: TCAGCGACGAAACGTGCAAGAG

*pvf2*\_RV: TTTGAATGCGGCGTCGTTCC

*pvf3*\_FW: TCGTGAAGAGCAGTAAGCATCG

*pvf3*\_RV: AGGTGCAACTCAGTATGGTGG

*dilp3*\_FW: GCAATGACCAAGAGAACTTTGGA

*dilp3*\_RV: GCAGGGAACGGTCTTCGA

*upd1*\_FW: CAGCGCACGTGAAATAGCAT

*upd1*\_RV: CGAGTCCTGAGGTAAGGGGA

*upd2*\_FW: GACTCTTCTCCGGCAAATCAGA

*upd2*\_RV: TGCTATCGCTGAGGCTCTCG

*CRTC*\_FW: GCAGCAGTACGCAACAAACC

*CRTC*\_RV: TTCACGTCGCTATTGAAGCCC

*CanA1*\_FW: CCGCCAGTGGAAACAAACAG

*CanA1*\_RV: GCGGAAGTGGAACATCATCG

Two-electrode clamp recordings in *Xenopus* oocytes {#s4-7}
---------------------------------------------------

TRPA1 currents in *Xenopus laevis* oocytes were recorded as previously described ([@bib38]). *Xenopus* ovaries were dissected and treated with 1.5 mg/ml collagenase A (Roche) and 1 mg/ml trypsin inhibitor (Roche) in OR2 Ringers (100 mM NaCl, 2 mM KCl, 1 mM MgCl~2~, 5 mM HEPES, pH = 7.5). The deflocculated oocytes were recovered at 18°C for 12 hr in OR3 medium (pH = 7.5): 50% Leibovitz's media L-15 (Sigma L1518), 13 mM HEPES, 90 μg/ml gentamicin, 90 μg/ml Fungizone, 90 μg/ml penicillin/streptomycin. *trpA1-C* and *trpA1-D* ([@bib35]) mRNAs were generated from pCS2 or pOX expression vectors with the mMessage mMachine kit (Ambion) and diluted in DEPC-treated water at the concentration of 1 μg/μl. Stage V-VI oocytes were injected with 50 nl prepared mRNA or water, and incubated at 18°C for 3 days for optimal expression. Two electrode voltage clamp recordings were performed at −80 mV with TURBO TEC-03X system and Cellwork software (NPI Electronics, Tamm, Germany), using ND96 buffer (96 mM NaCl, 1 mM MgCl~2~, 4 mM KCl, and 5 mM HEPES, pH = 7.6) with 1.8 mM CaCl~2~. In each experiment, we used 4 mM paraquat to treat the oocytes expressing TRPA1-C or -D, and added 0.01% AITC near the end of the recordings as a positive control.

Imaging cytosolic Ca^2+^ with GCaMP reporters {#s4-8}
---------------------------------------------

Cytosolic Ca^2+^ in stem cells was monitored ex vivo using *UAS-GCaMP6f* ([Figure 3E,E', F,F'](#fig3){ref-type="fig"}), *UAS-GCaMP6s* ([Figure 5](#fig5){ref-type="fig"} and Supplementary Movies) or *UAS-tdTomato-P2A-GCaMP5G* ([Figure 5---figure supplement 2A,A', B,B'](#fig5s2){ref-type="fig"}). In the latter case, tdTomato was used as an internal control. Young adult flies (4--7 days after eclosion) were first incubated at 29°C for 3 days to boost reporter expression before experiments. Intact midguts were dissected and handled in adult hemolymph-like (AHL) buffer. 1--2 intact midguts were placed in single wells of eight-well clear bottom cell culture chamber slides, gently oriented with Nylon mesh, and immersed in 200 µL AHL buffer for imaging. Images of the posterior midgut area (the region close to the middle midgut) were captured with a Zeiss LSM780 confocal microscope equipped with 10x lens. A z-stack of eight images covering one layer of the epithelium was recorded every 10 s for *UAS-GCaMP6s*, or every 20 s for *UAS-tdTomato-P2A-GCaMP5G*. Images before and after drug treatment are shown in z-max projection in [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}, while the time-lapse z-max projection movies for GCaMP6s are shown in [Videos 1](#media1){ref-type="other"}--[6](#media6){ref-type="other"}. Paraquat (Sigma Aldrich \#856177), AITC (Sigma Aldrich \#377430), and thapsigargin (Sigma Aldrich T9033) were dissolved in AHL buffer as 5x stock, and 50 µL drug stock was added to 200 µL imaging buffer to obtain desired final concentration. To quantify stem cells with high Ca^2+^ levels in most of the posterior region, Z-stack images were acquired on a Keyence microscope ([Figure 5](#fig5){ref-type="fig"}). All images were adjusted, assembled, and analyzed using NIH ImageJ.

Statistical methods {#s4-9}
-------------------

Statistical analyses were performed using Microsoft Excel (except for qPCR experiments, which were analyzed with Bio-Rad CFX Manager software). Average value and standard error of the mean (SEM) were calculated and shown in the figures. For comparison of data groups, p values were determined by Student's two-tail t-test with unequal variances, except for the comparison before and after drug treatment in [Figure 5D](#fig5){ref-type="fig"}, where the p value was determined by two-tail paired t-test. Double asterisks (\*\*) label a p value that is less than 0.01. The p value of more than 0.1 is labeled as 'not significant' (n.s.) or not labeled. Sample sizes were chosen empirically based on the observed effects and listed in the figure legends.
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Thank you for submitting your article \"Oxidative stress induces stem cell proliferation via TRPA1/RyR mediated Ca^2+^ signaling in the *Drosophila* midgut\" for consideration by *eLife*. Your article has been favorably evaluated by Jonathan Cooper (Senior Editor) and three reviewers, one of whom, Bruce Edgar (Reviewer \#1), is a member of our Board of Reviewing Editors. The following individual involved in review of your submission has agreed to reveal their identity: W. Daniel Tracey (Reviewer \#2).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

General assessment:

Xu et al. demonstrate that two conserved regulators of intracellular calcium, TrpA1 and RyR, are required for stem cell stress responses in the *Drosophila* gut, and provide evidence that one of these effectors, the Ca^2+^ channel TRPA1, may be activated by reactive oxygen species (ROS). They present an extensive and coherent set of tests supporting a model in which ROS trigger Ca^2+^ release via TRPA1 in ISCs, and that the Ca^2+^ in turn activates Ras/Mapk signaling to promote intestinal stem cell (ISC) divisions. The reviewers agreed that the experiments were generally performed to a high standard and that most of the conclusions were convincingly supported. However, no mechanistic insight was offered as to how ROS might activate TRPA1, or how Ca^2+^ might activate Ras, though similar effects have been reported before in other cell types. Given that other studies of the fly gut have concluded that Ras/Mapk activation in ISCs is effected non-cell autonomously, via the EGFR and ligands produced by other cells, the authors\' proposal that Ras is activated cell autonomously by Ca^2+^ is novel, interesting, and provocative.

Essential revisions:

1\) Two reviewers noted that authors\' proposal that the effect of ROS via Ca^2+^ on ERK and ISC division is cell autonomous, is not well supported and runs counter to many previous publications suggesting that ERK is activated by stress-dependent EGFR ligands non-cell autonomously supplied from other cells in the epithelium. The authors should either provide additional data supporting their cell-autonomous mechanism and ruling out non-autonomous mechanisms, or they should alter the model they present in [Figure 7](#fig7){ref-type="fig"}. In any case the autonomous vs. non-autonomous models should be carefully discussed.

2\) Along the same lines, reviewer \#3 notes that further data should be provided to rule out the role of CrebB and CanA as effectors of Ca^2+^, and to support the authors proposal that ERK is the principal Ca^2+^ effector.

3\) Reviewer \#2 notes a substantial body of relevant published work that was not cited or discussed (i.e. Du and Guntur papers). The manuscript should be revised to address these deficiencies.

4\) Two reviewers commented on the weakness of data showing the TRPA1 activation is sufficient to promote ISC divisions, and reviewer \#2 suggests an experiment to test this using a heat-activatable TRPA1 variant. If this experiment is possible, the authors should try it, or present some other type of data further supporting the sufficiency of TRPA1 mediated Ca^2+^ release to promote ISC division. This might also address point \#1 above.

5\) Reviewers 1and 3 discussed several issues with conclusions that could be clarified by counting ISCs and other cell types (EEs), from experiments that were already performed. This additional analysis should be provided if possible.

*Reviewer \#1:*

In this paper Xu et al. demonstrate that two conserved regulators of intracellular calcium, TrpA1 and RyR, are required for stem cell stress responses in the *Drosophila* gut, and provide evidence that one of these effectors, the Ca^2+^ channel TRPA1, may be activated by reactive oxygen species (ROS). They present an extensive and coherent set of tests supporting a model in which ROS trigger Ca^2+^ release via TRPA1 in ISCs, and that the Ca^2+^ in turn activates Ras/Mapk signaling to promote ISC divisions. No mechanistic insight is offered as to how ROS might activate TRPA1, or how Ca^2+^ might activate Ras, though similar effects have been reported before in neurons (also without mechanistic explanation). The results are consistent with a recent report in Nature from Jasper\'s group (Deng, 2016). Given that other studies of the fly gut have concluded that Ras/Mapk activation in ISCs is effected non-cell autonomously, via the EGFR and ligands produced by other cells, the authors\' proposal ([Figure 7](#fig7){ref-type="fig"}) that Ras is activated cell autonomously by Ca^2+^ is novel and interesting. However, this study does not definitively rule out non-cell autonomous signaling as a mechanism of ROS sensing or Ca^2+^ release, and so I think the model should be presented with reference to the rather different conclusions of previous work. Otherwise, apart from a few relatively minor issues with data analysis and interpretation, the paper is a nice story in principle appropriate for *eLife*. I list issues that need to be addressed in more detail below:

1\) Subsection "TRPA1 and RyR are required for stem cell damage response and self-renewal", third paragraph, [Figure 2E-H](#fig2){ref-type="fig"}: The authors show that the trpA1 and RyR RNAi\'s deplete Δ+ stem cells in 5 days. Nevertheless, they conclude that these RNAi\'s are not killing stem cells. This is not very convincing, and I think the number of stem cells should be counted using several assays, at several timepoints, since the issue of cell viability affects other critical results and the overall interpretation. For instance, in [Figure 3](#fig3){ref-type="fig"} we see decreases in ISC mitoses. These results would be confounded if the total number of ISCs decreases during the experiment.

2\) Similarly, in [Figure 4](#fig4){ref-type="fig"} we see increases in high Ca^2+^ cells after paraquat treatment in controls, but not in animals expressing RNAi against TRPA1. (Subsection "TRPA1 and RyR are required for normal and ROS-induced cytosolic Ca^2+^ 146 levels in ISCs", last paragraph, [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). But these increases could be due to division of cells with high Ca^2+^, rather than to an increase in the fraction of ISCs with high Ca^2+^. This would not occur in the RNAi treated ISCs, since the RNAi blocks their division. To address this potentially confounding issue the authors should count total ISC numbers in these experiments, as well as numbers of high Ca^2+^ cells, and display the fraction of ISCs that are Ca^2+^ high.

3\) As alluded to above, the regulation of Ras activity by Ca^2+^ is not explained mechanistically, and the authors\' model that the effect of ROS via Ca^2+^ is autonomous to stem cells is based on correlations that don\'t rule out other explanations. Although TrpA1 and RyR are clearly necessary for ISC activation, and although other treatments that increase Ca^2+^ are sufficient to activate ISCs (e.g. SERCA-RNAi), this paper doesn\'t provide strong evidence that activation of TrpA1 or RyR (in this case by ROS) is sufficient to activate ISCs. Moreover the data on ROS activation of TrpA1, though extensive and essential to the model ([Figure 7](#fig7){ref-type="fig"}), is the weakest in the paper. Thus, although the authors\' model is coherent and consistent with their data, it seems possible that the increase of Ca^2+^ and activation of ERK in ISCs actually involves signals from other cells in the epithelium, rather than a direct effect of ROS on TrpA1, as depicted in [Figure 7](#fig7){ref-type="fig"}. It would be interesting, for instance, to test whether the EGFR is required in this context (it is required for ISC responses to many stresses, but should not be required here). In the absence of experiments ruling out roles for other cell types, I feel the model figure ([Figure 7](#fig7){ref-type="fig"}) and Discussion should be modified to include the possibility that the oxidative damage signals are received by cells other than stem cells.

4\) The dpERK stainings in [Figure 5A-F](#fig5){ref-type="fig"} should be repeated with anti-TrpA1 RNAi\'s. Only tests with RyR-RNAi are shown.

5\) For most of the study, only TrpA1 is tested in detail. The manuscript would be better if the authors had carried through with a deeper analysis of RyR as well

*Reviewer \#2:*

The study of Xu et al. finds an important role for the *Drosophila* TRPA1 channel and Ryanodine Receptor channels in Reactive Oxygen Species (ROS) induced proliferation of intestinal stem cells. The combined evidence in support of the role of these two channels in this biological process as presented in the study is very strong. With respect to dTRPA1, the study points to a specific isoform (dTRPA1-D) in the sensing of ROS and the study also finds that Ras/Mapk function downstream of Ca influx/release that are triggered by dTRPA1 and Ryr respectively. The strength of the advance in the study is that it ties calcium signaling to ISC proliferation specifically in the context of ROS triggered proliferation and the study also specifically ties the calcium to dTRPA1 and Ryr. The authors do discuss the fact that a prior study has tied calcium to ISC proliferation through mGluRs and dietary glutamate. But some of the prior literature on dTRPA1 channels (in the context of ROS signaling) has not been adequately credited by the current study. For example, the dTRPA1-D isoform has been previously shown to be activated by ROS (*Drosophila* TRPA1 isoforms detect UV light via photochemical production of H2O2.

Guntur AR, Gu P, Takle K, Chen J, Xiang Y, Yang CH.Proc Natl Acad Sci U S A. 2015 Oct 20;112(42):) through a dual oxidase pathway in the ring gland. As well, a role for dTRPA1 in sensing ROS in the gut (also through dual oxidase) has been previously reported: TrpA1 Regulates Defecation of Food-Borne Pathogens under the Control of the Duox Pathway. Du EJ, Ahn TJ, Kwon I, Lee JH, Park JH, Park SH, Kang TM, Cho H, Kim TJ, Kim HW, Jun Y, Lee HJ, Lee YS, Kwon JY, Kang K.PLoS Genet. 2016 Jan 4;12(1)). This latter study also finds that it is the dTRPA1-D isoform which is activated by ROS and the study has not been cited in the current manuscript. Although Guntur et al. is briefly cited in the current study, the analysis of ROS activation by dTRPA1in heterologous oocytes do not significantly extend those that were initially reported by the studies of Guntur and Du. As such the new heterologous expression analyses should thus be presented as important confirmatory findings (even if investigating different chemical compounds to generate the ROS) with a bit more credit/discussion given to the prior studies. The new biological role for this function- in promoting ISC proliferation in response to ROS- is what is important here, and this will be of great interest to the readers of *eLife*.

Experimental points to be addressed:

The anti-dTRPA1 staining does not provide a clear description of where dTRPA-C/D is actually expressed in the gut. Reporters for dTRPA1-C/D are available from several labs and these could be used to more clearly illustrate the expression pattern.

*Reviewer \#3:*

In this manuscript, Xu et al. describe a novel mechanism controlling intestinal stem cell proliferation in *Drosophila*. They found that oxidative stress stimulates Ca^2+^ signaling by regulating TRPA1 and RyR. While the role of calcium signaling has previously been reported, this new study describes a different pathway causing changes in \[Ca^2+^\] and a different downstream effector cascade (Ras/ERK).

Experiments reported in this paper are generally well designed and properly controlled. They address an important question in the field, regarding the mechanisms that allow the integration of multiple signaling pathways in ISCs to control proliferation rates in response to stress (oxidative stress and tissue damage).

This study has the potential to be of interest for the large audience of *eLife*.

In my opinion, however, a few important points would need to be addressed to fully support the authors\' main conclusions:

The authors show that TRPA1 and RyR knock-down results in a loss of Dl+ stem cells. Because they argue that these cells do not die of apoptosis and do not commit to the enteroblast lineage, I am confused about what the fate of these ISCs is, after these genetic manipulations. The authors should at least test whether it promotes enteroendocrine cells fate by monitoring the number of prospero-positive cell in these epithelia. Also, it is possible that the expression of Δ is lost in these stem cells? Other ISC markers such as Sanpodo would be useful to test this hypothesis. Finally, are the single cell trpA and RyR mutant clones Dl-positive?

Altogether, these experiments would greatly help clarifying the fate of ISCs in which trpA or RyR activities is impaired.

The authors use paraquat exposure as an oxidative stress in most of their experiments. While the results are compatible with a regulation of Ca^2+^ signaling by ROS via a cell autonomous mechanism (including the control of TRPA1 activity), relatively simple experiments could be performed to rule out a non-cell autonomous mechanism following paraquat-induced tissue damage.

Does the expression of antioxidant proteins in ISCs prevent ROS-induced Ca^2+^ signaling? Do ISC-specific genetic manipulations that have been shown to induce ROS production in ISCs and promote cell proliferation (such as ND42 RNAi) increase Ca^2+^ signaling?

In the last part of this manuscript, the authors try to exclude the role of CanA1 and CrebB downstream of Ca^2+^ release, arguing that Ras/ERK is the main Ca^2+^ effector in ISCs. This is an important point as it has been previously published that these factors are part of the signaling pathway that regulate ISC proliferation in response to \[Ca\] changes, and this new study challenges this view. I believe that this conclusion needs to be supported by additional data.

The experiment in [Figure 6H](#fig6){ref-type="fig"} needs to be quantified and the other genetic manipulations (multiple RNAi lines targeting CanA1 and CrebB mentioned as \"not shown\" in the Results and Discussion) should be included in the main figures. It would be essential here to demonstrate that CanA1 and CrebB are dispensable for ROS- and SERCARNAi-mediated proliferation as suggested by the authors\' model.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for resubmitting your work entitled \"Oxidative stress induces stem cell proliferation via TRPA1/RyR mediated Ca^2+^ signaling in the *Drosophila* midgut\" for further consideration at *eLife*. Your revised article has been favorably evaluated by Jonathan Cooper (Senior Editor), a Reviewing Editor and two reviewers.

The consensus is that the manuscript has been improved, and we appreciate the new data you\'ve included as well as your editorial efforts. However, there are two remaining issues that are quite significant, and really need to be addressed before acceptance, as outlined below:

1\) One reviewer and the reviewing editor still believe the manuscript still falls short of establishing how, mechanistically, \[Ca^2+^\] activates ERK. A key issue is whether this happens directly, cell-autonomously, or through non-autonomous interactions between different cells in the gut epithelium. The old and new data do not resolve this issue, despite requests from reviewers. The model figure tries to cover both (or all possible) mechanisms and as such is a confusing conclusion -- in fact the model as presented will only serve to obscure whatever the real mechanism is, not to resolve it. We would very much like to see a clear resolution of this issue, so that this paper can be seen as an obvious advance over the recent similar publication from Deng et al. A reviewer\'s specific comments on this point follow: \"\[...\] the authors provide new data demonstrating that \[Ca^2+^\] controls the expression of Spitz and other RTK ligands. However, the authors appear to favor a model where \[Ca^2+^\] controls ERK activation directly through Src, but such activation is not demonstrated and the mechanism is unclear. As an example of this, the revised model still highlights a direct regulation of Ras/MAPK by Ca^2+^, and the authors discuss a scenario where Spitz induction is downstream of an initial direct activation of ERK rather than an integral part of the ERK activation mechanism. I think the two models (direct or autocrine/paracrine) could be easily be distinguished by testing whether EGFR and/or PVR are required for ISC proliferation induced by SERCARNAi and TRPA1-D overexpression, as suggested in the initial review. I believe that confirming that Ca^2+^ can activate ERK directly in ISCs (independently of a RTK signal) would greatly increase the impact of this study.\" Conversely, demonstrating the EGFR is essential for deregulated proliferation after Ca^2+^ signaling dysfunction would at least show that the mechanism is not simple and not cell autonomous.

2\) A second, and related, issue is how your results and conclusions relate to the Deng et al. publication. We feel that you should show the relevant data you have and clarify how your conclusions are different from Deng\'s and why. On this issue, a reviewer commented: \"some of the data required is not presented and some of the conflicting data not discussed. For example, the genetic interaction between SERCARNAi and CrebBRNAi (CrebBRNAi not being able to block SERCARNAi-induced proliferation) is still reported as \"data not shown\" in the revised version. This result is used as an important piece of data to support the authors\' conclusion that ERK is the major effector of Ca^2+^ in the control of ISC proliferation. Deng et al. reported that CrebBRNAi expression causes ISC loss: do the authors here find something different? Also, Deng et al. reported that dpERK levels are not affected by SERCARNAi expression. This inconsistency should be at least noted and discussed.\" Although we feel these issues are less pressing than \#1 above, we would appreciate some revisions to make it clear how your results and conclusions differ from those presented by Deng et al.

10.7554/eLife.22441.040

Author response

*Essential revisions: 1) Two reviewers noted that authors\' proposal that the effect of ROS via Ca2+ on ERK and ISC division is cell autonomous, is not well supported and runs counter to many previous publications suggesting that ERK is activated by stress-dependent EGFR ligands non-cell autonomously supplied from other cells in the epithelium. The authors should either provide additional data supporting their cell-autonomous mechanism and ruling out non-autonomous mechanisms, or they should alter the model they present in [Figure 7](#fig7){ref-type="fig"}. In any case the autonomous vs. non-autonomous models should be carefully discussed.*

Since it was reported that Ras activation increases Ca^2+^level in the ISCs (Deng et al., 2016), and EGFR ligand spi might act as a positive feedback signal for EGFR/Ras/MAPK pathway (Ammeux et al., 2016), the Ca^2+^mechanism and EGFR mechanism of Erk activation are not mutually exclusive but most likely intertwined. We have revised the model in [Figure 7](#fig7){ref-type="fig"} to reflect the multiple layers of regulation for Ras/MAPK signaling (explained in subsection "Signaling events downstream of cytosolic Ca^2+^in ISCs", second paragraph).

*2) Along the same lines, reviewer \#3 notes that further data should be provided to rule out the role of CrebB and CanA as effectors of Ca^2+^*, *and to support the authors proposal that ERK is the principal Ca^2+^ effector.*

We have quantified the epistasis analysis to demonstrate that CanA1 RNAi cannot reduce ISC proliferation caused by SERCA RNAi ([Figure 7---figure supplement 1E](#fig7s1){ref-type="fig"}). In addition, we are presenting the quantification of experiments using the CanA1 RNAi line ("FB5") from Dr. O'Farrell (Wong et al., 2014). Thus, we are very confident that SERCA RNAi- induced ISC proliferation does not depend on CanA1. In a modified screen to identify suppressor of SERCA RNAi, we have tested RNAi lines against calcium signaling effectors including CrebB (BL29332), CaMKII (BL29401, BL35330) and other calcineurin family proteins like CanB (BL27307), CanB2 (BL27270, BL38971), Pp2B-14D (BL25929), none of which rescued the over-proliferation phenotype.

*3) Reviewer \#2 notes a substantial body of relevant published work that was not cited or discussed (i.e. Du and Guntur papers). The manuscript should be revised to address these deficiencies.*

The papers suggested have been cited and discussed in the revised manuscript (see subsection "TRPA1 and RyR expression in the midgut", first paragraph and subsection "TRPA1-D in the midgut senses the oxidative stress associated with tissue damage", second paragraph).

*4) Two reviewers commented on the weakness of data showing the TRPA1 activation is sufficient to promote ISC divisions, and reviewer \#2 suggests an experiment to test this using a heat-activatable TRPA1 variant. If this experiment is possible, the authors should try it, or present some other type of data further supporting the sufficiency of TRPA1 mediated Ca2+ release to promote ISC division. This might also address point \#1 above.*

We have performed the mitosis quantification of midguts overexpressing TRPA1 isoforms C and D, as well as the heat-activatable TRPA1 isoform A ([Figure 4H](#fig4){ref-type="fig"}). The data support the sufficiency of TRPA1 mediated Ca^2+^release to promote ISC division.

*5) Reviewers 1and 3 discussed several issues with conclusions that could be clarified by counting ISCs and other cell types (EEs), from experiments that were already performed. This additional analysis should be provided if possible.*

We have added the time-course quantification of ISC ([Figure 1---figure supplement 1E](#fig1s1){ref-type="fig"}) and EE ([Figure 2M](#fig2){ref-type="fig"}) cell density in the revised manuscript. Besides, we have used EGT F/O (flp out tracing of ISC progenies) and MARCM systems for lineage tracing, and presented the images of midguts stained for the terminal differentiation markers Pros (for EE) and Pdm1 (for EC) ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). Our data suggest that while TRPA1 and RyR are required for maintaining basal level of cytosolic Ca^2+^and ISC self-renewal, and do not affect ISC differentiation.

*Reviewer \#1:*

*\[...\] 1) Subsection "TRPA1 and RyR are required for stem cell damage response and self-renewal", third paragraph, [Figure 2E-H](#fig2){ref-type="fig"}: The authors show that the trpA1 and RyR RNAi\'s deplete Δ+ stem cells in 5 days. Nevertheless, they conclude that these RNAi\'s are not killing stem cells. This is not very convincing, and I think the number of stem cells should be counted using several assays, at several timepoints, since the issue of cell viability affects other critical results and the overall interpretation. For instance, in [Figure 3](#fig3){ref-type="fig"} we see decreases in ISC mitoses. These results would be confounded if the total number of ISCs decreases during the experiment.*

The observation that anti-apoptotic p35 protein cannot rescue ISC proliferation defects ([Figure 1---figure supplement 2D-I, D](#fig1s2){ref-type="fig"}'-I'), and the added data of anti-cleaved caspase3 stainings ([Figure 1---figure supplement 2A-C](#fig1s2){ref-type="fig"}), demonstrate that trpA1 and RyR RNAi are not causing ISC apoptosis. We have taken the reviewer's advice and counted ISC and EE density after 3d, 5d, 7d of trpA1 or RyR RNAi expression. Although the signal of Dl-lacZ, indicating ISC maintenance, reduces significantly after 5 days of RNAi expression ([Figure 2D-F, 2K](#fig2){ref-type="fig"}), the density of overall esg+ stem cell population exhibits a much more moderate decrease ([Figure 1---figure supplement 1E](#fig1s1){ref-type="fig"}). Moreover, ISC differentiation activity (measured by Notch reporter Su(H)Gbe-GFP, [Figure 2G-I,L](#fig2){ref-type="fig"}) and EE density ([Figure 2M](#fig2){ref-type="fig"}) remains relatively stable during the time frame for most of our experiments. Our data suggest that trpA1 or RyR RNAi affect ISC proliferation but not differentiation, therefore the ISC population undergo gradual loss as they differentiate.

*2) Similarly, in [Figure 4](#fig4){ref-type="fig"} we see increases in high Ca^2+^ cells after paraquat treatment in controls, but not in animals expressing RNAi against TRPA1. (Subsection "TRPA1 and RyR are required for normal and ROS-induced cytosolic Ca^2+^ 146 levels in ISCs", last paragraph, [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). But these increases could be due to division of cells with high* Ca^2+^*, rather than to an increase in the fraction of ISCs with high* Ca^2+^*. This would not occur in the RNAi treated ISCs, since the RNAi blocks their division. To address this potentially confounding issue the authors should count total ISC numbers in these experiments, as well as numbers of high* Ca^2+^*cells, and display the fraction of ISCs that are* Ca^2+^*high.*

The increases of high Ca^2+^cells caused by paraquat treatment cannot be caused by expansion of cells with high Ca^2+^because the GCamP imaging lasted less than 20 min, not long enough for cell division. We have also stained flies used in [Figure 5](#fig5){ref-type="fig"} ([Figure 4](#fig4){ref-type="fig"} in original manuscript) with anti-GFP antibody (which recognizes GCamP6s) to visualize total ISC population. We did not observe significant changes in the total ISC number or density by trpA1 RNAi or RyR RNAi expression for the time frame we used to perform the GCamP imaging experiments ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}).

*3) As alluded to above, the regulation of Ras activity by Ca2+ is not explained mechanistically, and the authors\' model that the effect of ROS via Ca2+ is autonomous to stem cells is based on correlations that don\'t rule out other explanations. Although TrpA1 and RyR are clearly necessary for ISC activation, and although other treatments that increase Ca2+ are sufficient to activate ISCs (e.g. SERCA-RNAi), this paper doesn\'t provide strong evidence that activation of TrpA1 or RyR (in this case by ROS) is sufficient to activate ISCs. Moreover the data on ROS activation of TrpA1, though extensive and essential to the model ([Figure 7](#fig7){ref-type="fig"}), is the weakest in the paper. Thus, although the authors\' model is coherent and consistent with their data, it seems possible that the increase of Ca2+ and activation of ERK in ISCs actually involves signals from other cells in the epithelium, rather than a direct effect of ROS on TrpA1, as depicted in [Figure 7](#fig7){ref-type="fig"}. It would be interesting, for instance, to test whether the EGFR is required in this context (it is required for ISC responses to many stresses, but should not be required here). In the absence of experiments ruling out roles for other cell types, I feel the model figure ([Figure 7](#fig7){ref-type="fig"}) and Discussion should be modified to include the possibility that the oxidative damage signals are received by cells other than stem cells.*

Mitosis quantification of midguts overexpressing TRPA1 isoforms C and D, as well as the heat-activatable TRPA1 isoform A ([Figure 4H](#fig4){ref-type="fig"}) demonstrates that TRPA1 gain-of-function can significantly increase ISC division. As the reviewer pointed out, previous published studies have demonstrated that EGFR and its ligands induced after tissue damage can be responsible for Ras/MAPK/Erk activation. We do not think that our mechanism is mutually exclusive with the EGFR-related mechanism. Besides the paracrine ligand vn, EGFR in the progenitor population (ISCs are EBs) can act autonomously by sensing the autocrine ligands spi and Krn (Xu et al., 2011). It was reported before in fly cell lines that spi might act as a positive feedback mechanism for EGFR/Ras/MAPK signaling (Ammeux et al., 2016). Further, on-going work in our lab has identified spi as a target of Ras/MAPK signaling in the ISCs (Doupe et al., unpublished). By RT-qPCR of midgut mRNA we found that the transcription of spi is suppressed by trpA1 RNAi and induced by SERCA RNAi in the ISCs ([Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}). Therefore, TRPA1-mediated *Ca^2+^* might also be required for autocrine activation of EGFR/Ras/MAPK via spi, through or in parallel with the Src-mechanism that we have alluded to. On the other hand, it was reported that Ras activation causes increases in cytosolic *Ca^2+^* level (Deng et al., 2016). We hypothesize that the *Ca^2+^* and EGFR mechanisms are intertwined, amplify each other for activation, and turn off each other if one of them gets restricted. The hypothesis is reflected in the revised model in [Figure 8](#fig8){ref-type="fig"}.

*4) The dpERK stainings in [Figure 5A-F](#fig5){ref-type="fig"} should be repeated with anti-TrpA1 RNAi\'s. Only tests with RyR-RNAi are shown.*

We have added the imaging experiments as suggested ([Figure 6C,G](#fig6){ref-type="fig"}). As control, wild type midguts (EGT\>Luc RNAi) was processed alongside the experimental groups of [Figure 6C and G](#fig6){ref-type="fig"}, and the levels of pErk signal look the same as [Figure 6A](#fig6){ref-type="fig"}.

*5) For most of the study, only TrpA1 is tested in detail. The manuscript would be better if the authors had carried through with a deeper analysis of RyR as well*

We have added quantification of RyR RNAi effect on EE and EB population ([Figure 2L-M](#fig2){ref-type="fig"}); and added the observation that Ras1 is epistatic to RyR RNAi for ISC proliferation ([Figure 7---figure supplement 2](#fig7s2){ref-type="fig"}). Because RyR is not at the plasma membrane, we cannot perform the direct measurement of RyR response to ROS as we did with TRPA1, due to the limitation of our equipment.

*Reviewer \#2:*

*The study of Xu et al. finds an important role for the Drosophila TRPA1 channel and Ryanodine Receptor channels in Reactive Oxygen Species (ROS) induced proliferation of intestinal stem cells. The combined evidence in support of the role of these two channels in this biological process as presented in the study is very strong. With respect to dTRPA1, the study points to a specific isoform (dTRPA1-D) in the sensing of ROS and the study also finds that Ras/Mapk function downstream of Ca influx/release that are triggered by dTRPA1 and Ryr respectively. The strength of the advance in the study is that it ties calcium signaling to ISC proliferation specifically in the context of ROS triggered proliferation and the study also specifically ties the calcium to dTRPA1 and Ryr. The authors do discuss the fact that a prior study has tied calcium to ISC proliferation through mGluRs and dietary glutamate. But some of the prior literature on dTRPA1 channels (in the context of ROS signaling) has not been adequately credited by the current study. For example, the dTRPA1-D isoform has been previously shown to be activated by ROS (Drosophila TRPA1 isoforms detect UV light via photochemical production of H2O2.*

*Guntur AR, Gu P, Takle K, Chen J, Xiang Y, Yang CH.Proc Natl Acad Sci U S A. 2015 Oct 20;112(42):) through a dual oxidase pathway in the ring gland. As well, a role for dTRPA1 in sensing ROS in the gut (also through dual oxidase) has been previously reported: TrpA1 Regulates Defecation of Food-Borne Pathogens under the Control of the Duox Pathway. Du EJ, Ahn TJ, Kwon I, Lee JH, Park JH, Park SH, Kang TM, Cho H, Kim TJ, Kim HW, Jun Y, Lee HJ, Lee YS, Kwon JY, Kang K.PLoS Genet. 2016 Jan 4;12(1)). This latter study also finds that it is the dTRPA1-D isoform which is activated by ROS and the study has not been cited in the current manuscript. Although Guntur et al. is briefly cited in the current study, the analysis of ROS activation by dTRPA1in heterologous oocytes do not significantly extend those that were initially reported by the studies of Guntur and Du. As such the new heterologous expression analyses should thus be presented as important confirmatory findings (even if investigating different chemical compounds to generate the ROS) with a bit more credit/discussion given to the prior studies. The new biological role for this function- in promoting ISC proliferation in response to ROS- is what is important here, and this will be of great interest to the readers of eLife.*

We cited the studies of Guntur et al. 2015 in the original manuscript but did not discuss it. Now we have cited and discussed both studies (subsection "TRPA1 and RyR expression in the midgut", first paragraph and subsection "TRPA1-D in the midgut senses the oxidative stress associated with tissue damage", second paragraph). Guntur et al. found that TRPA1-C and TRPA1-D isoforms are H2O2-sensitive and that their endogenous expressions in the ring gland, or ectopic expression in other tissues, confer UV light sensitivity via sensing UV light-induced H2O2 production. Although Du et al., 2016 reported that TRPA1-D mediates much stronger NaOCl^-^induced current than TRPA1-C, it seems inconsistent that they could rescue uracil-dependent defecation defects in trpA1 mutant flies with TRPA1-C overexpression but not with TRPA1-D. We found that TRPA1-D, rather than TRPA1-C, exhibits response to paraquat ([Figure 4A-B](#fig4){ref-type="fig"}), and that TRPA1-D overexpression in ISCs causes a stronger proliferation phenotype than TRPA1-C ([Figure 4C-F,H](#fig4){ref-type="fig"}).

*Experimental points to be addressed:*

*The anti-dTRPA1 staining does not provide a clear description of where dTRPA-C/D is actually expressed in the gut. Reporters for dTRPA1-C/D are available from several labs and these could be used to more clearly illustrate the expression pattern.*

The signal to noise ratio is not ideal for immunostaining with anti-dTRPA1 antibody in the midgut ([Figure 3A-B](#fig3){ref-type="fig"}). Personal communication with Dr. KyeongJin Kang (who used the antibody for the Du et al., 2016 paper) also confirmed that the antibody seems quite dirty. To confirm trpA1 expression, we inserted Gal4 at the C terminal of endogenous dTRPA1 with CRISPR/Cas9 ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). With this Gal4 line we could detect trpA1 expression in some ISCs in the posterior midgut areas that is close to the middle midgut region as well as the posterior end of the midgut, where ISC proliferation is most active ([Figure 3C](#fig3){ref-type="fig"}). We further demonstrated that for trpA1 mutant flies, there is no calcium influx in ISCs in response to the trpA1 agonist AITC ([Figure 3E,E',F,F'](#fig3){ref-type="fig"}). Moreover, knockdown of trpA1 in Dl+ stem cells with Dl-Gal4 inhibits ISC proliferation ([Figure 3---figure supplement 2B](#fig3s2){ref-type="fig"}). These data serve as functional evidence that trpA1 is expressed in the ISCs.

*Reviewer \#3:*

*\[...\] In my opinion, however, a few important points would need to be addressed to fully support the authors\' main conclusions:*

*The authors show that TRPA1 and RyR knock-down results in a loss of Dl+ stem cells. Because they argue that these cells do not die of apoptosis and do not commit to the enteroblast lineage, I am confused about what the fate of these ISCs is, after these genetic manipulations. The authors should at least test whether it promotes enteroendocrine cells fate by monitoring the number of prospero-positive cell in these epithelia. Also, it is possible that the expression of Δ is lost in these stem cells? Other ISC markers such as Sanpodo would be useful to test this hypothesis. Finally, are the single cell trpA and RyR mutant clones Dl-positive?*

*Altogether, these experiments would greatly help clarifying the fate of ISCs in which trpA or RyR activities is impaired.*

A more careful quantification of esg+ ([Figure 1---figure supplement 1E](#fig1s1){ref-type="fig"}), Su(H)Gbe+ ([Figure 2L](#fig2){ref-type="fig"}), and Pros+ cell density ([Figure 2M](#fig2){ref-type="fig"}) has been performed. Besides, lineage-tracing experiments with EGT F/O system, or MARCM, suggest that stem cells deficient for trpA1 or RyR can still differentiate into mature progenies ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). These data support our current hypothesis that trpA1 or RyR knockdown allows for ISC differentiation but blocks ISC self-renewal and proliferation. Therefore, trpA1 or RyR RNAi will cause a gradual loss of esg+ stem cells as they differentiate. During the time frame for most of our experiments, total ISC density (esg+) exhibits very modest change with trpA1 or RyR RNAi expression in ISCs, even though the hallmark of ISC self-renewal (Dl+) and damage-induced ISC proliferation decrease significantly. Since the flies lack ISC self-renewal activity, the total ISC population will gradually decrease as the flies age, and eventually be unable to replenish the mature cell types during tissue turnover.

*The authors use paraquat exposure as an oxidative stress in most of their experiments. While the results are compatible with a regulation of Ca^2+^ signaling by ROS via a cell autonomous mechanism (including the control of TRPA1 activity), relatively simple experiments could be performed to rule out a non-cell autonomous mechanism following paraquat-induced tissue damage.*

*Does the expression of antioxidant proteins in ISCs prevent ROS-induced Ca^2+^ signaling? Do ISC-specific genetic manipulations that have been shown to induce ROS production in ISCs and promote cell proliferation (such as ND42 RNAi) increase Ca^2+^ signaling?*

As previously reported, tissue damage can induce ligands expression from the microenvironment, for example the EGFR ligand vn from the visceral muscle, to stimulate ISC proliferation (Jiang et al., 2011). We do not think the non-cell autonomous mechanisms are mutually exclusive with the Ca^2+^ signaling mechanism we have identified. In the revised manuscript we have incorporated the known mechanism via EGFR into our model ([Figure 8](#fig8){ref-type="fig"}). Expression of the antioxidant protein CncC in ISC can reduce its proliferation (Hochmuth et al., 2011). Due to the complexity of the genotype we have not performed GCamP imaging to confirm if ROS-induction of Ca^2+^ signaling is decreased by CncC, or if CncC knockdown can induce Ca^2+^ in ISCs, but we have obtained indirect evidence that CnCC RNAi-induced ISC hyper-proliferation status is dependent on trpA1 ([Figure 4G](#fig4){ref-type="fig"}).

*In the last part of this manuscript, the authors try to exclude the role of CanA1 and CrebB downstream of Ca^2+^ release, arguing that Ras/ERK is the main Ca^2+^ effector in ISCs. This is an important point as it has been previously published that these factors are part of the signaling pathway that regulate ISC proliferation in response to \[Ca\] changes, and this new study challenges this view. I believe that this conclusion needs to be supported by additional data.*

*The experiment in [Figure 6H](#fig6){ref-type="fig"} needs to be quantified and the other genetic manipulations (multiple RNAi lines targeting CanA1 and CrebB mentioned as \"not shown\" in the Results and Discussion) should be included in the main figures. It would be essential here to demonstrate that CanA1 and CrebB are dispensable for ROS- and SERCARNAi-mediated proliferation as suggested by the authors\' model.*

As the reviewer suggested, we quantified mitosis ([Figure 7---figure supplement 1E](#fig7s1){ref-type="fig"}) for genotypes used in [Figure 7---figure supplement 1A-B](#fig7s1){ref-type="fig"} ([Figure 6H](#fig6){ref-type="fig"} in original manuscript). Quantification of mitosis for an additional validated RNAi line against CanA1 (FB5 from Dr. O'Farrell, [Figure 7---figure supplement 1F](#fig7s1){ref-type="fig"}) also demonstrates that CanA1 RNAi cannot suppress hyper-proliferation caused by SERCA RNAi.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

*The consensus is that the manuscript has been improved, and we appreciate the new data you\'ve included as well as your editorial efforts. However, there are two remaining issues that are quite significant, and really need to be addressed before acceptance, as outlined below:*

*1) One reviewer and the reviewing editor still believe the manuscript still falls short of establishing how, mechanistically, \[Ca++\] activates ERK. A key issue is whether this happens directly, cell-autonomously, or through non-autonomous interactions between different cells in the gut epithelium. The old and new data do not resolve this issue, despite requests from reviewers. The model figure tries to cover both (or all possible) mechanisms and as such is a confusing conclusion -- in fact the model as presented will only serve to obscure whatever the real mechanism is, not to resolve it. We would very much like to see a clear resolution of this issue, so that this paper can be seen as an obvious advance over the recent similar publication from Deng et al. A reviewer\'s specific comments on this point follow: \"\[...\] the authors provide new data demonstrating that \[Ca^2+^\] controls the expression of Spitz and other RTK ligands. However, the authors appear to favor a model where \[Ca^2+^\] controls ERK activation directly through Src, but such activation is not demonstrated and the mechanism is unclear. As an example of this, the revised model still highlights a direct regulation of Ras/MAPK by Ca^2+^, and the authors discuss a scenario where Spitz induction is downstream of an initial direct activation of ERK rather than an integral part of the ERK activation mechanism. I think the two models (direct or autocrine/paracrine) could be easily be distinguished by testing whether EGFR and/or PVR are required for ISC proliferation induced by SERCARNAi and TRPA1-D overexpression, as suggested in the initial review. I believe that confirming that Ca++ can activate ERK directly in ISCs (independently of a RTK signal) would greatly increase the impact of this study.\" Conversely, demonstrating the EGFR is essential for deregulated proliferation after Ca++ signaling dysfunction would at least show that the mechanism is not simple and not cell autonomous.*

As suggested by the reviewers, we performed the genetic epistasis experiments and found that *EGFR* RNAi can suppress *SERCA* RNAi-induced ISC proliferation ([Figure 7---figure supplement 1B and F](#fig7s1){ref-type="fig"}). In addition, we have shown that activation of EGFR by *spi* over-expression even allows ISC to bypass the requirement of TRPA1 for proliferation ([Figure 7F](#fig7){ref-type="fig"}). While there are various RTK ligands that might activate Ras/MAPK, sometimes in a redundant fashion, the intensity of signal they trigger differs by several orders of magnitude. In particular, Spi is known as a strong EGFR ligand compared to weak non-autonomous ligand such as Vn (Austin et al., 2014). And *spi* expression is required in the ISCs for neoplastic proliferation caused by *Notch* RNAi (Patel et al., 2015), suggesting a non-redundant role of autocrine Spi-EGFR signaling in supporting ISC proliferation in some contexts. Ongoing work in our lab suggests that *spi* might be the target of transcription factors downstream of EGFR/Ras/MAPK pathway (DamID analysis by Doupé et al.) in the ISCs. Therefore, Spi could be involved in a positive feedback mechanism to enhance EGFR/Ras/MAPK signaling in the ISCs. We are now proposing that both EGFR and \[Ca^2+^\] are required for MAPK activation and ISC proliferation, and autocrine Spi-EGFR signaling might participate in amplifying MAPK activity, downstream of \[Ca^2+^\] (revised model in [Figure 8](#fig8){ref-type="fig"}). In the revised model, \[Ca^2+^\]-sensitive Src could be a possible mechanism for the initial stimulation of Ras/MAPK by \[Ca^2+^\], as the kinetics of which is considered to be much faster than transcriptional regulation in the neurons (Randlett et al., 2015; Rosen et al., 1994). We have added the mitosis quantification showing that *Src* is epistatic to *trpA1* RNAi ([Figure 6---figure supplement 2H](#fig6s2){ref-type="fig"}), and that *Src64B* RNAi can partially suppress *SERCA* RNAi-induced ISC proliferation ([Figure 6---figure supplement 2I](#fig6s2){ref-type="fig"}).

Specifically, to address the issue raised by the reviewer we have now revised [Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}, [Figure 7](#fig7){ref-type="fig"}, [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}, [Figure 8](#fig8){ref-type="fig"}, reassigned [Figure 7---figure supplement 2](#fig7s2){ref-type="fig"}, adjusted the figure legends accordingly, and added the following paragraphs to the main text:

"In neurons, a common mechanism by which Ca^2+^ regulates Ras/MAPK is through Ca^2+^ sensitive Src kinases (Cullen and Lockyer, 2002), in a process faster than any transcriptional response (Randlett et al., 2015; Rosen et al., 1994). \[...\] These data suggest that Src might mediate the activation of Ras/MAPK by cytosolic Ca^2+^ in ISCs."

"Previous studies have documented that receptor tyrosine kinase (RTK) EGFR is required for MAPK activity and ISC proliferation (Jiang et al., 2011). \[...\] Altogether, these results suggest that positive RTK signaling feedback loops may play a role in the activation of Ras/MAPK in the context of Ca^2+^ signaling."

"Cross-talk between Ca^2+^ signaling and EGFR

Prior to our study, it has been shown that paracrine ligands such as Vn from the visceral muscle, and autocrine ligands such as Spi and Pvf ligands from the stem cells, can stimulate ISC proliferation via RTK-Ras/MAPK signaling (Bond and Foley, 2012; Jiang et al., 2011; Xu et al., 2011). \[...\] As *spi* is induced by EGFR-Ras/MAPK signaling in *Drosophila* cells (Ammeux et al., 2016), and DNA binding mapping (DamID) analyses from our lab and others indicate that *spi* might be a direct target of transcriptional factors downstream of EGFR-Ras/MAPK in the ISCs (Jin et al., 2015), the autocrine ligand Spi might act as a positive feedback mechanism for EGFR-Ras/MAPK signaling in ISCs."

*2) A second, and related, issue is how your results and conclusions relate to the Deng et al. publication. We feel that you should show the relevant data you have and clarify how your conclusions are different from Deng\'s and why. On this issue, a reviewer commented: \"some of the data required is not presented and some of the conflicting data not discussed. For example, the genetic interaction between SERCARNAi and CrebBRNAi (CrebBRNAi not being able to block SERCARNAi-induced proliferation) is still reported as \"data not shown\" in the revised version. This result is used as an important piece of data to support the authors\' conclusion that ERK is the major effector of Ca++ in the control of ISC proliferation. Deng et al. reported that CrebBRNAi expression causes ISC loss: do the authors here find something different? Also, Deng et al. reported that dpERK levels are not affected by SERCARNAi expression. This inconsistency should be at least noted and discussed.\" Although we feel these issues are less pressing than \#1 above, we would appreciate some revisions to make it clear how your results and conclusions differ from those presented by Deng et al.*

As requested by the reviewers, we have included the epistasis analysis of *SERCA* RNAi with *CrebB* RNAi and *CRTC* RNAi ([Figure 7---figure supplement 1D-F](#fig7s1){ref-type="fig"}). In addition, as the reviewers pointed out, Deng et al. claimed that dpERK levels are not affected by *SERCA* RNAi expression (in Extended Figure 9C from their paper, [Author response image 1](#fig9){ref-type="fig"}). To address the inconsistency, we found that after ISCs start massive expansion with prolonged high Ca^2+^ induction, pErk returns to normal levels in many ISCs (probably through some negative feedback mechanism) and is non-autonomously induced in some ECs ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}), resulting in a diffusive and more variable pattern of activation. Such kinetics we observed might explain why Deng et al. failed to detect pErk induction, especially when they were imaging very small fields of 2-3 cells for midgut samples at late stages of Ca^2+^ signaling.10.7554/eLife.22441.038Author response image 1.**DOI:** [http://dx.doi.org/10.7554/eLife.22441.038](10.7554/eLife.22441.038)

Specifically, to address the issue raised by the reviewer we have now added [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}, revised [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}, adjusted the figure legends accordingly, and added the following paragraphs to the main text:

"It should be noted that the best timing to detect autonomous activation of dpErk by high Ca^2+^ in the ISCs is before they enter the hyper-proliferative stage. Once ISCs start to expand massively following prolonged high Ca^2+^ induction, pErk returns to normal levels in many ISCs and is non-autonomously induced in some ECs, resulting in a diffusive activation pattern ([Figure 6---figure supplement 1A-C](#fig6s1){ref-type="fig"})."

"Furthermore, while *Ras1* RNAi could suppress *SERCA* RNAi-induced ISC proliferation, neither *CanA1* RNAi nor *CrebB* RNAi could ([Figure 7---figure supplement 1C-G](#fig7s1){ref-type="fig"}), and *CRTC* RNAi could only confer moderate suppression of ISC hyper-proliferation ([Figure 7---figure supplement 1E-F](#fig7s1){ref-type="fig"})."
